UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2001

OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM __________ TO _________

COMMISSION FILE NUMBER: 000-25132

MYMETICS CORPORATION
(Exact name of Registrant as specified in its charter)

         DELAWARE                                               25-1741849
(State or other jurisdiction of                             (I.R.S. Employer
incorporation or organization)                              Identification No.)

                        50-52 AVENUE CHANOINE CARTELLIER
                         69230 SAINT-GENIS LAVAL, FRANCE
                    (Address of principal executive offices)

33 4 72 39 52 09
(Registrant's telephone number, including area code)

ICHOR CORPORATION
(Former name, former address and former fiscal year,
if changed since last report)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:

Class                                  Outstanding at August 8, 2001
-----                                  -----------------------------

Common Stock, $0.01 par value          46,011,962


TABLE OF CONTENTS

PART I.  FINANCIAL INFORMATION.................................................................................... 4

   ITEM 1.     FINANCIAL STATEMENTS............................................................................... 4
   ITEM 2.     MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS..............11
   ITEM 3.     QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT.....................................................12

PART II.  OTHER INFORMATION.......................................................................................13

   ITEM 1.     LEGAL PROCEEDINGS..................................................................................13
   ITEM 2.     CHANGES IN SECURITIES AND USE OF PROCEEDS..........................................................13
   ITEM 4.     SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS................................................13
   ITEM 6.     EXHIBITS AND REPORTS ON FORM 8-K...................................................................14

SIGNATURES........................................................................................................15

2

FORWARD-LOOKING STATEMENTS

Statements in this report, to the extent that they are not based on historical events, constitute forward-looking statements. Forward-looking statements include, without limitation, statements regarding the outlook for future operations, forecasts of future costs and expenditures, the evaluation of market conditions, the outcome of legal proceedings, the adequacy of reserves or other business plans. Investors are cautioned that forward-looking statements are subject to an inherent risk that actual results may vary materially from those described herein. Factors that may result in such variance, in addition to those accompanying the forward-looking statements, include changes in interest rates, prices and other economic conditions; actions by competitors; natural phenomena; actions by governmental authorities; uncertainties associated with legal proceedings; technological development; future decisions by management in response to changing conditions; and misjudgments in the course of preparing forward-looking statements.

3

PART I. FINANCIAL INFORMATION

ITEM 1 FINANCIAL STATEMENTS

MYMETICS CORPORATION (F/K/A ICHOR CORPORATION)
(A DEVELOPMENT STAGE COMPANY)

CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS OF EURO)

(UNAUDITED)

                                                 June 30, 2001    December 31, 2000
                                                 -------------    -----------------

ASSETS

Current

   Cash                                               E  2,091              E   185

   Short term investments                                  234                  149

   Receivables                                              62                   64

   Loan fees                                             3,294                   87

   Prepaid expenses                                         27                   11
                                                      --------              -------

                                                         5,708                  496

Patents and others                                         155                  129
                                                      --------              -------

                                                      E  5,863              E   625

LIABILITIES

Current

   Accounts payable                                   E    606              E   646

   Taxes and social costs payable                           87                  109

   Note payable                                            938                  385

   Other                                                     7                    8
                                                      --------              -------

                                                         1,638                1,148

Payable to shareholders                                    242                  242

SHAREHOLDERS' EQUITY

Common Stock                                               525                  119

Paid-in capital                                         18,486                  806

Deficit accumulated during the development stage       (15,016)              (1,690)

Cumulative translation adjustment                          (12)                  --
                                                      --------              -------

                                                         3,983                 (765)
                                                      --------              -------

                                                      E  5,863              E   625
                                                      ========              =======

The accompanying notes are an integral part of these financial statements.

4

MYMETICS CORPORATION (F/K/A ICHOR CORPORATION)
(A DEVELOPMENT STAGE COMPANY)

CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS OF EURO, EXCEPT FOR PER SHARE AMOUNTS)

(UNAUDITED)

                                             For the Six       For the Six        Total Accumulated
                                             Months Ended      Months Ended       During the
                                             June 30, 2001     June 30, 2000      Development Stage
                                             -------------     -------------      -----------------



Revenue                                       E     --           E     67           E    224

EXPENSES

   Research and development                        184                 72                546

   General and administrative                      441                 50              1,164

   Bank fee                                     12,666                 --             13,472

   Interest                                         42                 --                 59
                                              --------           --------           --------

                                                13,333                122             15,241



Interest Income                                      6                  1                  6
                                              --------           --------           --------

Loss before provision for income tax           (13,327)               (54)           (15,011)

Provision for income tax                            --                 --                  6
                                              --------           --------           --------

Net loss                                      E(13,327)          E    (54)          E(15,017)



Basic and diluted loss per share              E  (0.34)          E   0.00           E  (0.39)
                                              ========           ========           ========

The accompanying notes are an integral part of these financial statements.

5

MYMETICS CORPORATION (F/K/A ICHOR CORPORATION)
(A DEVELOPMENT STAGE COMPANY)

CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS OF EURO, EXCEPT FOR PER SHARE AMOUNTS)

(UNAUDITED)

                                       For the Three     For the Three
                                       Months Ended      Months Ended
                                       June 30, 2001     June 30, 2000
                                       -------------     -------------

Revenue                                   E    --           E    27

EXPENSES

   Research and development                    70                27


   General and administrative                 273                21


   Bank fee                                 9,612                --

   Interest                                    23                --
                                          -------           -------

                                            9,978                48



Interest Income                                 3                --
                                          -------           -------

Net Loss                                   (9,975)              (21)
                                          =======           =======

Basic and diluted loss per share E (0.23) E 0.00

The accompanying notes are an integral part of these financial statements.

6

MYMETICS CORPORATION (F/K/A ICHOR CORPORATION)
(A DEVELOPMENT STAGE COMPANY)

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(IN THOUSANDS OF EURO)

(UNAUDITED)

For the Three    For the Three
Months Ended     Months Ended
June 30, 2001    June 30, 2000
-------------    -------------

Net loss                                      E(9,975)          E   (21)

Other comprehensive loss:

   Cumulative translation adjustment              (12)               --
                                              -------           -------

Total comprehensive loss                      E(9,987)          E   (21)
                                              =======           =======

The accompanying notes are an integral part of these financial statements.

7

MYMETICS CORPORATION (F/K/A ICHOR CORPORATION)
(A DEVELOPMENT STAGE COMPANY)

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(IN THOUSANDS OF EURO)

(UNAUDITED)

For the Six        For the Six
Months Ended       Months Ended
June 30, 2001      June 30, 2000
-------------      -------------

Net loss                                      E(13,327)          E    (54)

Other comprehensive loss:

   Cumulative translation adjustment               (12)                --
                                              --------           --------

Total comprehensive loss                      E(13,339)          E    (54)
                                              ========           ========

The accompanying notes are an integral part of these financial statements.

8

MYMETICS CORPORATION (F/K/A ICHOR CORPORATION)
(A DEVELOPMENT STAGE COMPANY)

CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS OF EURO)

(UNAUDITED)

                                                       For the Six        For the Six      Total Accumulated
                                                       Months Ended       Months Ended     During the
                                                       June 30, 2001      June 30, 2000    Development Stage
                                                       -------------      -------------    -----------------

Cash flow from operating activities:

Net loss                                                 E(13,327)          E    (54)          E(15,017)

Adjustments to reconcile net loss to net cash

   Provided by(used in) operating activities:

      Amortization                                         12,726                  3             12,831

      Fee payable in common stock                              --                 --                806

      Decrease(increase) in receivable                         39                  3                (25)

      Increase(decrease) in accounts payable                 (335)               124                311

      Increase(decrease) in taxes and

        social costs payable                                  (22)                22                 87

      Other                                                   (16)                10                (19)
                                                         --------           --------           --------

                                                             (935)               108             (1,026)

Cash flows from investing activities:

   Patents and other                                          (44)               (13)              (234)

   Short-term investments                                     (85)              (130)              (234)

   Purchase of subsidiary, net of cash acquired                13                 --                 13
                                                         --------           --------           --------

                                                             (116)              (143)              (455)

Cash flows from financing activities:

   Proceeds from issuance of common stock                   2,124                 --              2,243

   Borrowing from shareholders                                 --                 --                242

   Increase in note payable                                   553                 --                937

   Loan fees                                                 (144)                --               (274)
                                                         --------           --------           --------

                                                            2,533                 --              3,148

Effect on foreign exchange rate on cash                       424                 --                424
                                                         --------           --------           --------

Net change in cash                                          1,906                (35)             2,091

Cash, beginning of period                                     185                 36                 --
                                                         --------           --------           --------

Cash, end of period                                      E  2,091           E      1           E  2,091
                                                         ========           ========           ========

The accompanying notes are an integral part of these financial statements.

9

MYMETICS CORPORATION (F/K/A ICHOR CORPORATION)
(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2001
(UNAUDITED)

NOTE 1. BASIS OF PRESENTATION

Effective March 28, 2001 Mymetics Corporation (a United States company, formally known as Ichor Corporation) (the "Corporation") and Hippocampe S.A. (a French company, "Hippocampe") combined their operations whereby Hippocampe's stockholders exchanged their stock for the common stock of the Corporation. Because Hippocampe is a continuing entity, this combination is accounted for as a reverse purchase. Consistent with the accounting for a reverse purchase, these financial statements represent the historical financial statements of Hippocampe. The results of operations of the Corporation are included in these statements since the date of acquisition.

Hippocampe is a company in the development stage involved in the research and development of human and animal vaccines and therapies in the field of retroviral and viral autoimmune diseases. Hippocampe's main research efforts have been concentrated in the prevention and treatment of the AIDS virus. All of Hippocampe's activities have been conducted in Europe.

The accompanying financial statements of the Corporation are unaudited. However, in the opinion of management, they include all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows of the Corporation for the specified periods taking into account the exchange transaction described above.

All adjustments made during the six-month period ended June 30, 2001, were of a normal, recurring nature. The amounts presented for the six-month period ended June 30, 2001, are not necessarily indicative of the results of operations for a full year. Additional information is contained in the audited consolidated financial statements and accompanying notes of Hippocampe included in the Corporation's Definitive Information Statement on Schedule 14C dated April 25, 2001, and these financial statements and notes should be read in conjunction with such Definitive Information Statement.

NOTE 2. REPORTING CURRENCY

Consistent with the location of its activities, beginning January 1, 1999, the Corporation adopted the euro (E) as its corporate currency. Accordingly, the Corporation prepared its 2001 and 2000 financial statements in euros.

NOTE 3. EARNINGS (LOSS) PER SHARE

Basic earnings (loss) per share is calculated by dividing the net income or loss available to common shareholders by the weighted average number of common shares outstanding during the six-month periods ended June 30, 2001 and 2000, respectively. The weighted average number of shares outstanding was 38,758,952 and 33,311,398 for the six-month periods ended June 30, 2001 and 2000, respectively. The weighted average number of shares outstanding was 43,818,135 and 33,311,398 for the three-month periods ended June 30, 2001 and 2000, respectively.

10

Diluted earnings (loss) per share takes into account common shares outstanding, potentially dilutive common shares and preferred shares convertible into common shares. The conversion of convertible preferred shares, stock options and warrants have not been reflected as exercised for purposes of computing the diluted loss per share for the six-month periods ended June 30, 2001 and 2000, respectively, since the exercise of such options and warrants would be anti-dilutive.

NOTE 4. WARRANTS

Under a loan agreement with MFC Merchant Bank ("MFC Bank"), the Corporation issued warrants on March 28, 2001, which entitle MFC Bank to purchase approximately 6,801,693 shares of the Corporation's common stock. The warrants will entitle MFC Bank to convert an amount equal to the maximum of the credit facility including unpaid interest plus arrangement and retainer fees associated with the loan agreement. The warrants are exercisable within a three-year period beginning August 2000 at approximately E0.2319 per common share. The intrinsic value of the beneficial conversion feature associated with the warrants was calculated at the grant date using the Black-Scholes model to be E15,938,000 and has been recorded as paid-in capital. E12,666,000 of this amount has been charged to bank fee expense in the current period and the balance of E3,272,000, which is included in loan fees in the June 30, 2001 consolidated balance sheet, is being amortized through August 2001, the remainder of the loan term, on the interest method.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of the results of operations and financial condition of the Corporation for the six-month and three month periods ended June 30, 2001 should be read in conjunction with the Corporation's consolidated financial statements and related notes included elsewhere herein.

RESULTS OF OPERATIONS - SIX MONTHS ENDED JUNE 30, 2001 COMPARED TO SIX MONTHS ENDED JUNE 30, 2000

Revenues of the six months ended June 30, 2001 was nil compared to E67,000 for the six months ended June 30, 2000, primarily as a result of decreased contract research activity. Interest income was E6,000 and E1,000 for the six months ended June 30, 2001 and 2000, respectively.

Costs and expenses increased to E13,333,000 for the six months ended June 30, 2001 compared to E122,000 for the six months ended June 30, 2000, primarily as a result of an increase in bank fees of E12,666,000 for the six months ended June 30, 2001 (see Note 4 to the Corporation's Consolidated Financial Statements included herein).

The Corporation reported a net loss of E13,327,000, or E0.34 per share, for the six months ended June 30, 2001, compared to E54,000, or E0.00 per share, for the six months ended June 30, 2000.

11

RESULTS OF OPERATIONS - THREE MONTHS ENDED JUNE 30, 2001 COMPARED TO THREE MONTHS ENDED JUNE 30, 2000

Revenues for the three months ended June 30, 2001 was nil compared to E27,000 for the three months ended June 30, 2000, primarily as a result of decreased contract research activity. Interest income was E3,000 and nil for the three months ended June 30, 2001 and 2000, respectively.

Costs and expenses increased to E9,978,000 for the three months ended June 30, 2001 compared to E48,000 for the three months ended June 30, 2000, primarily as a result of an increase in bank fees of E9,612,000 for the three months ended June 30, 2001 (see Note 4 to the Corporation's Consolidated Financial Statements included herein).

The Corporation reported a net loss of E9,975,000, or E0.23 per share, for the three months ended June 30, 2001, compared to E21,000, or E0.00 per share, for the three months ended June 30, 2000.

LIQUIDITY AND CAPITAL RESOURCES

The Corporation had cash in the amount of E2,091,000 at June 30, 2001, compared to E185,000 at December 31, 2000.

Net cash used by operating activities was E935,000 for the six months ended June 30, 2001, compared to cash provided of E108,000 for the six months ended June 30, 2000. A decrease in accounts payable used cash of E335,000 for the six months ended June 30, 2001 compared to an increase of the same providing cash of E124,000

Investing activities used cash in the amount of E116,000 for the six months ended June 30, 2001 compared to E143,000 for the same period last year. Short term investment used cash of E85,000 for the six months ended June 30, 2001 compared to E130,000 for the six months ended June 30, 2000.

Financing activities provided cash of E2,533,000 for the six months ended June 30, 2001 compared to nil in the same period last year. Proceeds from the issuance of common stock provided cash of E2,124,000 in the six months ended June 30, 2001. Increases in borrowing pursuant to a revolving term facility provided cash of E553,000 during the current period. The revolving term facility is in the principal amount of up to E1.3 million and matures on August 31, 2001. At June 30, 2001, the Corporation had borrowed an aggregate of E938,000 pursuant to this revolving term facility.

The Corporation expects that it will require substantial additional capital to continue its research and development, clinical studies and regulatory activities necessary to bring its potential products to market and to establish production, marketing and sales capabilities. The Corporation anticipates its operations will require approximately E1.5 million in the year ending December 31, 2001. The Corporation will seek to raise the required capital from lenders and/or equity or debt issuances. However, there can be no assurance that the Corporation will be able to raise additional capital on terms satisfactory to the Corporation, or at all, to finance its operations. In the event that the Corporation is not able to obtain such additional capital, it would be required to restrict or even halt its operations.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

MYMETICS

Mymetics is exposed to market risk from changes in interest rates which could affect its financial condition and results of operations. Mymetics has not entered into derivative contracts for its own account to hedge against such risk.

INTEREST RATE RISK

Fluctuations in interest rates may affect the fair value of financial instruments sensitive to interest rates. An increase in interest rates may decrease the fair value and a decrease in interest rates may increase the fair value of such financial instruments. Mymetics has debt obligations which are sensitive to interest rate fluctuations. The following table provides information about Mymetics exposure to interest rate fluctuations for the carrying amount of such debt obligations as of December 31, 2000 and expected cash flows from these debt obligations:

                                                                           Expected Future Cash Flow
                                                            ------------------------------------------------------
                                                                  Year Ending December 31,
                                        Carrying   Fair     ---------------------------------------
                                         Value     Value    2001     2002    2003     2004     2005     Thereafter
                                        --------   -----    ----     ----    ----     ----     ----     ----------
Debt obligations (1) ..................  E 384     E 384    E 384    E --    E --     E --     E --        E --


(1) Debt obligations consist of the Corporation's (as successor to Hippocampe's obligations) notes payable.

12

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS

On June 30, 2001, the Corporation closed on a private offering of 1,333,333 shares of its common stock at E1.77 per share for an aggregate price of E2,355,600 (the "Private Placement"). The Private Placement was exempt from registration under the Securities Act of 1933 (the "1933 Act") pursuant to Regulation S of the 1933 Act. The shares sold pursuant to the Private Placement were sold to foreign investors meeting the requirements of Regulation S of the 1933 Act.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

On July 19, 2001, the Corporation held an annual meeting of its shareholders in Saint-Genis Laval, France (the "Annual Meeting"). At the Annual Meeting, the Corporation's shareholders were given the opportunity to vote on the following items: (i) to elect three directors, (ii) to approve an amendment to the Corporation's Certificate of Incorporation to change the Corporation's name from "Ichor Corporation" to "Mymetics Corporation" and (iii) to approve the Ichor Corporation 2001 Stock Option Plan. Set forth below is a chart listing the items voted on at the Annual Meeting and numbers and manner of votes cast for each such item.

                                             Votes For         Votes Against         Abstentions         Non-Votes
                                             ---------         -------------         -----------         ---------

1.      Election of Directors:
        Patrice Pactol (1)                  35,419,233           2,252,326                  --              20,250
        Robert Demers (2)                   35,419,233           2,252,326                  --              20,250
        Michael K. Allio (2)                35,419,233           2,252,326                  --              20,250
        Pierre-Francois Serres (3)                  --                  --                  --                  --
        John M. Musacchio (4)                       --                  --                  --                  --


2.      Name Change                         20,655,402          14,897,006           2,137,151              20,250

3.      Approval of Ichor
        Corporation 2001 Stock              32,357,413           2,252,326                  --           3,077,670
        Option Plan


(1) Elected as a Class 2 Director whose term will expire in 2002
(2) Elected as a Class 1 Director whose term will expire in 2004
(3) Existing Director whose term expires in 2003
(4) Existing Director whose term expires in 2002

13

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

(a)               EXHIBITS

           EXHIBIT
           NUMBER                 DESCRIPTION
           ------                 -----------

           (3)(i)                 Articles of Incorporation of the Corporation
                                  (as amended through July 25, 2001)
           (3)(ii)                Bylaws of the Corporation
           (10)(i)                Employment Agreement dated May 3, 2001,
                                  between Pierre-Francois Serres and the
                                  Corporation
           (10)(ii)               Services Agreement dated May 31, 2001 between
                                  the Corporation and MFC Merchant Bank, S.A.
           10(iii)                Indemnification Agreement dated March 28, 2001
                                  between the Corporation and MFC Bancorp Ltd.
           10(iv)                 Ichor Corporation 2001 Stock Option Plan
           99                     Definitive Information Statement on Schedule
                                  14C filed on April 25, 2001(1)

------------------

(1) Incorporated by reference from the Corporation's Schedule 14C filed on April 25, 2001

(b) REPORTS ON FORM 8-K

The Corporation filed the following reports with respect to the indicated items during its second quarter ended June 30, 2001:

Form 8-K dated April 12, 2001, regarding the share exchange transaction between the Corporation and the shareholders of Hippocampe S.A. effective March 28, 2001.

Item 7. Financial Statements and Exhibits

Form 8-K dated May 23, 2001, regarding the amendment to the Corporation's Certificate of Incorporation to increase the authorized number of its shares of common stock, $0.01 par value, from 30,000,000 to 80,000,000.

14

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: August 14, 2001                    MYMETICS CORPORATION

                                          By:   /s/ John M. Musacchio
                                             ---------------------------
                                                Chief Financial Officer

15

Exhibit 3(i)

CERTIFICATE OF INCORPORATION

OF

ICHOR Corporation

1. The name of the corporation is ICHOR Corporation (the "Corporation").

2. The name of its registered agent is The Corporation Trust Company and the address of its registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, Wilmington, New Castle County, Delaware 19801.

3. The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware, as from time to time amended.

4. The total number of shares of all classes of stock which the Corporation shall have authority to issue is Thirty-Five Million (35,000,000) shares, of which Five Million (5,000,000) shares shall be preferred stock, $.01 par value, and Thirty Million (30,000,000) shares shall be common stock, $.0l par value. The preferred stock of the Corporation may be issued from time to time in one or more series. The Board of Directors is expressly authorized, in a resolution or resolutions providing for the issue of such preferred stock, to fix, state and express the powers, rights, designations, preferences, qualifications, limitations and restrictions thereof and to fix the number of shares of such series.

Except as otherwise provided by law, the shares of stock of the Corporation, regardless of class, may be issued by the Corporation from time to time in such amounts, for such consideration and for such corporate purposes as the Corporation's Board of Directors may from time to time determine.

5. In furtherance and not in limitation of the powers conferred by law, the Board of Directors is expressly authorized to make, alter or repeal the By-laws of the Corporation. but any By-laws so made, altered or repealed may be amended or repealed by the stockholders entitled to vote thereon.

6. (a) The Corporation shall, to the fullest extent permitted by
Section 145 of the General Corporation Law of the State of Delaware, as amended from time to time, indemnify every person who is or was a party, or is threatened to be made a party,


to (i) any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, or (ii) any threatened pending or completed action or suit by or in the right of the Corporation to procure a judgment in its favor, by reason of the fact that such person serves or has served at any time as a Director or officer of the Corporation, or who at the request of the Corporation serves or at any time has served as a Director or officer of another corporation (including subsidiaries of the Corporation) or of any partnership, joint venture, trust or other enterprise, from and against any and all of the expenses, liabilities or other matters referred to in or covered by said law. Such indemnification shall continue as to a person who has ceased to be a Director or officer and shall inure to the benefit of the heirs, executors and administrators of such a person. The Corporation may also indemnify any and all other persons whom it shall have power to indemnify under any applicable law from time to time in effect to the extent authorized by the Board of Directors and permitted by such law. The indemnification provided by this Article 6 shall not be deemed exclusive of any other rights to which any person may be entitled under any provision of the Certificate of Incorporation, other By-Law, agreement, vote of stockholders or disinterested Directors, or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office.

(b) To the extent that a director, officer, employee or agent of the Corporation, or a person serving in any other enterprise at the request of the Corporation, shall have been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in subsection (a) of this Article 6 or in defense of any claim, issue or matter therein, he shall be indemnified against all expenses (including attorneys' fees) actually and reasonably paid or incurred by him in connection therewith.

(c) Any indemnification under this Article 6 (unless ordered by a court) shall be made by the Corporation only as authorized in the specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the circumstance because he has met the applicable standard of conduct set forth in this Article 6. Such determination shall be made (1) by the board of directors by a majority vote of a quorum consisting of Directors who were not parties to such action, suit or proceeding, or (2) if such a quorum is not obtainable, or, even if obtainable a quorum of disinterested Directors so directs, by independent legal counsel, who may be one

2

of the regular independent legal counsel of the Corporation, in a written opinion, or (3) by the stockholders.

(d) Expenses (including attorneys' fees) incurred by a person in defending any civil, criminal, administrative or investigative action, suit or proceeding may be paid by the Corporation in advance of the final disposition of such action, suit or proceeding upon receipt by the Corporation of an undertaking in writing by or on behalf of the person to be indemnified to repay such amount if it shall ultimately be determined that he is not entitled to be indemnified by the Corporation as authorized in this Article 6. Such expenses (including attorneys' fees) incurred by other employees and agents may be so paid upon such terms and conditions, if any, as the Board of Directors deems appropriate.

(e) The Corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Corporation. or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against him and incurred by him in any such capacity, or arising out of his status as such, whether or not the Corporation would have the power to indemnify him against such liability under the provisions of this Article 6.

(f) For purposes of this Article 6, the term "corporation" shall include constituent corporations referred to in Subsection (h) of Section 145 of the General Corporation Law of the State of Delaware (or any similar provision of applicable law at the time in effect), and references to "other enterprises" shall include employee benefit plans.

7. A director of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (A) for any breach of the director's duty of loyalty to the Corporation or its stockholders, (B) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (C) under Section 174 of the Delaware General Corporation Law or (D) for any transaction from which the director derives an improper personal benefit. If the Delaware General Corporation Law is amended after this Article 7 becomes effective to authorize elimination or limitation of liability of directors, then, upon the effective date of any such amendment, the liability of a director of the Corporation shall, without further

3

act, be eliminated or limited to the fullest extent permitted by the Delaware General Corporation Law as so amended. Any repeal or modification of this article by the stockholders of the Corporation shall not adversely affect any right or protection of a director of the Corporation existing at the time of such repeal or modification.

8. The Corporation shall not be governed by the provisions of Section 203 of the Delaware General corporation Law.

9. In elections for directors, voting need not be by ballot, unless required by vote of the stockholders before the voting for the election of directors begins.

10. The name and mailing address of the incorporator is as follows:

Richard D. Rose One Riverfront Center Pittsburgh, Pennsylvania 15222

I, THE UNDERSIGNED, being the incorporator hereinbefore named, for the purpose of forming a corporation pursuant to the General Corporation Law of the State of Delaware, do make this certificate, hereby declaring and certifying that this my act and deed and the facts herein stated are true, and accordingly have hereunto set my hand this 16th day of September, 1996.

/s/ RICHARD D. ROSE
-------------------------------
Richard D. Rose
Incorporator

4

CERTIFICATE OF MERGER
OF
PDG REMEDIATION, INC.
INTO
ICHOR CORPORATION

Pursuant to Section 252 of the

General Corporation Law of the State of Delaware

ICHOR CORPORATION, a corporation organized and existing under the laws of the State of Delaware, does hereby certify:

FIRST: That the name and state of incorporation of each of the constituent corporations of the merger (the "Constituent

Corporations") are as follows;

               Name                                      State of Incorporation
               ----                                      ----------------------

         PDG Remediation, Inc.                                Pennsylvania
         ICHOR Corporation                                    Delaware

SECOND: That an agreement and plan of merger (the "Merger Agreement"), dated as of October 1, 1996, between the Constituent Corporations was approved, adopted, certified, executed and acknowledged by each of the Constituent Corporations in accordance with the requirements of subsection (c) of Section 252 of the General Corporation Law of the State of Delaware and Sections 1921-26 of the Pennsylvania Business Corporation Law of 1988, as amended (15 Pa. C.S. Sections 1921-26).

THIRD: That the name of the corporation surviving the merger is ICHOR Corporation, a Delaware corporation (the "Surviving Corporation").


FOURTH: That the Certificate of Incorporation of ICHOR Corporation, as currently in effect, shall be the Certificate of Incorporation of the Surviving Corporation.

FIFTH: That the executed Merger Agreement is on file at the principal place of business of the Surviving Corporation. The address of said principal place of business is 300 Oxford Drive, Monroeville, Pennsylvania 15146.

SIXTH: That a copy of the Merger Agreement will be furnished by the Surviving Corporation, upon request and without cost, to any stockholder or shareholder of any Constituent Entity.

SEVENTH: That the authorized capital stock of each of the Constituent Entities is as follows:

PDG Remediation, Inc.              30,000,000 shares of common
                                   stock, $.01 par value, and
                                   5,000,000 shares of preferred
                                   stock, $.0l par value

ICHOR Corporation                  30,000,000 shares of common
                                   stock, $.01 par value, and
                                   5,000,000 shares of preferred
                                   stock, $.01 par value

IN WITNESS WHEREOF, this Certificate of Merger has been signed by the President and attested by the Assistant Secretary of the Surviving Corporation

this 12th day of November, 1996

ATTEST:                                ICHOR CORPORATION


By /s/ CHRISTINA L. GOETZ              By /s/ JOHN M. MUSACCHIO
   -------------------------              ---------------------------
Title  Assistant Secretary             Title  President
     -----------------------                 ------------------------
       Christina L. Goetz                     John M. Musacchio


CERTIFICATE OF DESIGNATIONS
ICHOR CORPORATION

ICHOR Corporation, a Delaware corporation (the "Corporation"), desires to designate the rights and preferences of a series of preferred stock (the "Series 1 Preferred Stock") in accordance with the Corporation's Certificate of Incorporation and Section 151 o( the Delaware General Corporation Law. Leonard Petersen, Director of the Corporation, hereby certifies the following:

1. This Certificate is the act and deed of Leonard Petersen, Director of the Corporation. The facts stated in this Certificate are true.

2. The resolutions attached as Exhibit A were duly adopted by the board of directors effective March 5, 1998.

3. The number of shares of Series 1 Preferred Stock to which the resolutions at Exhibit A apply is 500,000 shares.

DATED March 5, 1998.

/s/ LEONARD PETERSEN
-----------------------
Leonard Petersen
Director

DATED March 5, 1998.

/s/ KIM C. MOLLER
-----------------------
(Signature of Notary)

KIM C. MOLLER
(Legibly Print or Stamp Name of Notary)

Notary public in and for British Columbia,
Canada, residing at Vancouver, British Columbia

My commission expires at the pleasure of her majesty the Queen in the Right of the Province of British Columbia


EXHIBIT A

DIRECTORS' RESOLUTIONS

BE IT RESOLVED THAT:

1. A first series of Preferred Stock be and is hereby designated as "5% Cumulative Redeemable Convertible Preferred Stock, Series 1" (the "Series 1 Preferred Stock").

2. The number of Series 1 Preferred Stock in the capital of the Corporation be and is hereby fixed at 500,000.

3. The Series 1 Preferred Stock shall have attached thereto the special rights and restrictions, as a series, in substantially the form set out in Schedule "A" hereto, with such changes, additions and alterations thereto as the President or Secretary may deem necessary or desirable, and that the constating documents of the Corporation be amended as necessary to incorporate same.

4. Any one director or officer of the Corporation be and is hereby authorized to execute and deliver the Certificate of Designations relating to the Series 1 Preferred Stock for and on behalf of the Corporation.


SCHEDULE "A"

The first series of Preferred Stock, designated 5% Cumulative Redeemable Convertible Preferred Stock, Series 1 (the "Series 1 Shares") shall have attached thereto, in addition to the rights, privileges, restrictions, conditions and limitations attaching to the Preferred Stock as a class, the following rights, privileges, restrictions and conditions (the "Series 1 Provisions"):

1. GENERAL

1.1 DEFINITIONS

Where used in these Series 1 Provisions, the following words and phrases shall, unless there is something in the context otherwise inconsistent therewith, have the following meanings, respectively:

(a) "business day" means a day other than a Saturday, Sunday or any other day treated as a holiday in the State of Delaware;

(b) "close of business" means the normal closing hour of the principal office of the transfer agent for the Series 1 Shares;

(c) "Common Shares" means the Common Shares in the Corporation as such shares were constituted on February 20, 1998, or as such shares may be changed from time to time, provided that any adjustment in the Conversion Rate required by clause 3.5 hereof has been made;

(d) "Conversion Price" means 90% of the Current Market Price;

(e) "Conversion Rate" means at any time means the number of Common Shares into which one Series 1 Share may be converted at such time in accordance with the provisions of Section 3;

(f) "Current Market Price" of the Common Shares on any date means the arithmetic weighted average of the closing prices for sales of Common Shares on the designated exchange based upon the 20 day average closing trading price on the designated exchange, provided that in the event that the Common Shares are not listed on any stock exchange or through any quotation system, Current Market Price shall be determined by the board of directors of the Corporation, which determination shall be conclusive;

(g) "designated exchange" means on any date, the stock exchange or quotation system through which the largest number of Common Shares of the Corporation traded over the 20 trading day period immediately preceding such date;

(h) "director" means a director of the Corporation for the time being and "directors" or "board of directors" means the board of directors of the Corporation or, if duly


2

constituted and empowered, the executive committee of the board of directors of the Corporation for the time being, and reference, without further elaboration, to action by the directors means either action by the directors of the Corporation as a board or action by the said executive committee as such committee;

(i) "herein", "hereto", "hereunder", "hereof', "hereby" and similar expressions mean or refer to these Series 1 Provisions and not to any particular Section, clause, subclause, subdivision or portion hereof, and the expressions "Section", "clause" and "subclause" followed by a number or a letter mean and refer to the specified Section, clause or subclause hereof;

(j) "Initial Issue Date" means the first date on which any Series 1 Shares are issued and outstanding;

(k) "Issue Price" means $10.00 per Series 1 Share;

(l) "Junior Shares" means any shares in the capital of the Corporation ranking after or subordinate to the Series 1 Shares as to the payment of dividends or the return of capital, including, without limiting the generality of the foregoing, the Common Shares;

(m) "Liquidation Distribution" means the distribution of assets of the Corporation on the liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary, or any other distribution of assets of the Corporation among its shareholders for the purpose of winding up its affairs;

(n) "ranking as to capital" means ranking or priority with respect to the distribution of assets in the event of a Liquidation Distribution;

(o) "Series 1 Holder" means a person recorded on the securities register of the Corporation as being the registered holder of one or more Series 1 Shares;

(p) "trading day" means any day on which the designated exchange is open for business and on which the relevant class of shares of the Corporation are traded; and

(q) "transfer agent" means the corporation or corporations from time to time appointed by the directors as the transfer agent for the Series 1 Shares and, in the event that no such person is appointed, "transfer agent" means the Corporation.

1.2 GENDER, ETC.

Words importing only the singular number include the plural and vice versa and words importing any gender include all genders.


3

1.3 CURRENCY

All monetary amounts referred to herein shall be in lawful money of the United States.

1.4 HEADINGS

The division of these Series 1 Provisions into Sections, clauses, subclauses or other subdivisions and the insertion of headings are for convenience of reference only and shall not affect the construction or interpretation hereof.

1.5 BUSINESS DAY

In the event that any date upon which any dividends on the Series 1 Shares are payable by the Corporation, or upon or by which any other action is required to be taken by the Corporation or any Series 1 Holder hereunder, is not a business day, then such dividend shall be payable or such other action shall be required to be taken on or by the next succeeding day which is a business day.

2. DIVIDENDS

2.1 DECLARATION AND PAYMENT OF DIVIDENDS

The holders of Series 1 Shares shall be entitled to receive and the Corporation shall pay thereon, as and when declared by the board of directors out of funds legally available for such purpose, fixed preferential cumulative cash dividends at the rate of $0.50 per share per annum. Such dividends shall accrue, whether or not earned or declared, from and including the date of issue of such shares and, subject as hereinafter provided, shall be payable in equal quarterly installments of $0.125 per share on the last day of each of March, June, September and December in each year (each of which date is hereinafter referred to as a "dividend payment date"). The first dividend payment date shall be March 31. 1998.

2.2 AMOUNT OF DIVIDEND

The amount of the dividend for any period which is less than a full quarter with respect to any Series 1 Share:

(i) which is issued, redeemed or purchased; or

(ii) where assets of the Corporation are distributed to the Series 1 Holders pursuant to Section 6 hereof;

shall be equal to the amount calculated by multiplying $0.125 by a fraction the numerator of which is the number of days in such quarter for which such share has been outstanding (including the dividend payment date at the beginning of such quarter if such share was outstanding on that date excluding the next succeeding dividend payment date if such share was outstanding on that date), and the denominator of which is the number of days in such quarter


4

(including the dividend payment date at the beginning thereof and excluding the next succeeding dividend payment date).

The amount of dividend payable in respect of each Series 1 Share on the first dividend payment date following the Initial Issue Date shall be that proportion of $0.125 which the number of days from and including the Initial Issue Date to but excluding such dividend payment date is to the total number of days in the 3 month period immediately preceding such dividend payment date.

2.3 CUMULATION OF DIVIDENDS

If on any dividend payment date a dividend accrued to and payable on such date is not paid in full on the Series 1 Shares then issued and outstanding, the dividend or the unpaid part thereof shall be paid on a subsequent dividend payment date or dividend payment dates determined by the board of directors on which the Corporation shall have sufficient moneys legally available for the payment of the same. The Series 1 Holders shall not be entitled to any dividends other than or in excess of the fixed preferential cumulative dividends provided for in this Section 2.

3. CONVERSION

3.1 RIGHT TO CONVERT

Upon and subject to the terms and conditions hereinafter set forth, the holders of Series 1 Shares shall have the right, at any time and from time to time, up to the close of business on March 6, 2003, or, in the case of Series 1 Shares called for redemption, to the close of business on the business day immediately preceding the date fixed for redemption, whichever is earlier (provided, however, that if the Corporation shall fail to redeem such Series 1 Shares in accordance with the notice of redemption the right of conversion shall thereupon be restored as if such call for redemption had not been made), to convert all or any part of their Series 1 Shares into fully paid and non-assessable Common Shares, at the Conversion Rate in effect on the date of conversion. Unless and until adjusted in accordance with these Series 1 Provisions, the Conversion Rate shall be equal to the quotient obtained when the Issue Price plus all accrued and unpaid dividends thereon outstanding as at the date of conversion is divided by the Conversion Price.

3.2 CONVERSION PROCEDURE

The conversion right provided for in clause 3.1 may be exercised by completing and executing a notice of conversion on the certificate or certificates representing the Series 1 Shares in respect of which the holder thereof desires to exercise such right of conversion or such other form of notice approved by the Corporation and by delivering the said notice and certificate or certificates to the transfer agent for the Series 1 Shares at any office for the transfer of the Series 1 Shares. The said notice of conversion shall be signed by such holder or by his duly authorized attorney or agent with signature guaranteed in a manner satisfactory to the transfer agent and shall specify the number of Series 1 Shares which the Series 1 Holder desires to have converted.


5

The transfer form in the certificate or certificates in question need not be endorsed, except in the circumstances contemplated by clause 3.3. If less than all the Series 1 Shares represented by a certificate or certificates are to be converted, the Series 1 Holder shall be entitled to receive, at the expense of the Corporation, a new certificate representing the Series 1 Shares represented by the certificate or certificates surrendered as aforesaid which are not to be converted.

3.3 PERSON TO WHOM COMMON SHARES WILL BE ISSUED

On any conversion of Series 1 Shares the share certificates for Common Shares resulting therefrom shall be issued at the expense of the Corporation in the name of the registered holder of the Series 1 Shares converted or in such name or names as such registered holder may direct in writing, provided that such registered holder shall pay any applicable security transfer taxes. In any case where the Common Shares are to be issued in the name at a person other than the holder of the converted Series 1 Shares, the transfer form on the back of the certificates in question shall be endorsed by the registered holder of the Series 1 Shares or his duly authorized attorney or agent, with signature guaranteed in a manner satisfactory to the transfer agent.

3.4 EFFECTIVE DATE OF CONVERSION

Each Series 1 Holder whose shares are to be converted in whole or in part (or any other person or persons in whose name or names any certificates representing Common Shares are issued as provided in clause 3.3) shall be deemed to have become the holder of record of the Common Shares into which such Series 1 Shares are converted, for all purposes, on the respective dates of receipt by the transfer agent of the certificate or certificates representing the Series 1 Shares to be converted as provided in clause 3.2, notwithstanding any delay in the delivery of the certificate or certificates representing the Common Shares into which such Series 1 Shares have been converted and, effective as of and throughout such respective dates, the Series 1 Holder shall cease to be registered as the holder of record of the Series 1 Shares so converted.

3.5 ADJUSTMENT OF CONVERSION RATE

3.5.1    If and whenever at any time and from time to time the Corporation shall
         (i) subdivide, redivide or change its then outstanding Common Shares
         into a greater number of Common Shares, (ii) reduce, combine or
         consolidate or change its then outstanding Common Shares into a lesser
         number of Common Shares, or (iii) issue Common Shares (or securities
         exchangeable or convertible into Common Shares) to the holders of all
         or substantially all of its then outstanding Common Shares by way of
         stock dividend or other distribution (other than a stock dividend paid
         in the ordinary course) (any of such events being herein called a
         "Common Share Reorganization"), the Conversion Rate shall be adjusted
         effective immediately after the record date at which the holders of
         Common Shares are determined for the purpose of the Common Share
         Reorganization to provide that each Series 1 Holder shall thereafter be
         entitled to receive such number of Common Shares as he would have been
         entitled to receive had he exercised his conversion rights immediately
         prior to such Common Share Reorganization.


6

3.5.2    If and whenever there is a capital reorganization of the Corporation
         not otherwise provided for in this clause 3.5 or a consolidation,
         merger, arrangement or amalgamation (statutory or otherwise) of the
         Corporation with or into another body corporate (any such event being
         called a "Capital Reorganization"), any Series 1 Holder who has not
         exercised his right of conversion prior to the record date for such
         Capital Reorganization shall be entitled to receive and shall accept,
         upon the exercise of such right at any time after the record date for
         such Capital Reorganization, in lieu of the number of Common Shares to
         which he was theretofore entitled upon conversion, the aggregate number
         of shares or other securities of the Corporation or of the corporation
         or body corporate resulting, surviving or continuing from the Capital
         Reorganization that such holder would have been entitled to receive as
         a result of such Capital Reorganization if, on the record date, he had
         been the registered holder of the number of Common Shares to which he
         was theretofore entitled upon conversion, subject to adjustment
         thereafter in accordance with provisions the same, as nearly as may be
         possible, as those contained in this clause 3.5; provided that no such
         Capital Reorganization shall be carried into effect unless all
         necessary steps shall have been taken so that the Series 1 Holder shall
         thereafter be entitled to receive such number of shares or other
         securities of the Corporation or of the corporation or body corporate
         resulting, surviving or continuing from the Capital Reorganization.

3.5.3    In case of any reclassification of, or other change in, the outstanding
         Common Shares other than a Common Share Reorganization or a Capital
         Reorganization, the right of conversion shall be adjusted immediately
         after the record date for such reclassification or other change so that
         Series 1 Holders shall be entitled to receive, upon the exercise of
         such right at any time after the record date of such reclassification
         or other change, such shares, securities or rights as they would have
         received had such Series 1 Shares been converted into Common Shares
         immediately prior to such record date subject to adjustment thereafter
         in accordance with provisions, the same as nearly may be possible, as
         those contained in this clause 3.5.

3.6      ENTITLEMENT TO DIVIDENDS

         Each Series 1 Holder on the record date for any dividend declared

payable on the Series 1 Shares shall be entitled to such dividend notwithstanding that any Series 1 Share owned by him is converted after such record date and before the payment date of such dividend. The registered holder of any Common Share resulting from any conversion effected pursuant to this
Section 3 shall be entitled to rank equally with the registered holders of all other Common Shares in respect of all dividends declared payable to holders of Common Shares of record on or after the date of conversion.

3.7 AVOIDANCE OF FRACTIONAL SHARES

In any case where a fraction of a Common Share would otherwise be issuable on conversion of one or more Series 1 Shares, the Corporation shall, at its option, either (i) adjust such fractional interest by payment by check in an amount equal to the then current market value of such fractional interest or
(ii) issue in respect of such fraction a scrip certificate transferable by


7

delivery entitling the holder thereof and of other similar certificates aggregating one full Common Share, upon surrender of such certificates at such place as may be designated therein, to obtain from the Corporation a full Common Share and to receive a share certificate therefor; such checks shall be payable to the holders thereof in lawful money of the United States at par at any branch in the United States of the Corporation's bankers for the time being and such scrip certificates shall be in such form and shall be subject to such terms and conditions as the directors may determine and shall provide that the holder thereof shall not thereby be a shareholder and shall not be entitled to receive dividends or to any other rights of a shareholder. The amount of any cash adjustment shall equal the current market value of such fractional interest computed on the basis of the last sale price (or average of the bid and asked prices if there were no sales) per share for the Common Shares on the NASDAQ Stock Market (or. if such shares are not then listed and posted for trading on such stock exchange, on such stock exchange or quotation system through which such shares are listed and posted for trading as may be selected by the board of directors) on the business day next preceding the conversion date. In the event that the Common Shares of the Corporation are not listed on any stock exchange or through any quotation system the current market value shall be determined by the board of directors which determination shall be conclusive.

4. REDEMPTION

4.1 OPTIONAL REDEMPTION

4.1.1    The Corporation, upon giving notice as hereinafter provided, may redeem
         all at any time and part from time to time of the then outstanding
         Series 1 Shares, on payment for each share to be redeemed of the Issue
         Price together in each case with an amount equal to all accrued and
         unpaid cumulative preferential dividends thereon calculated to but
         excluding the date fixed for redemption, the whole constituting and
         herein referred to as the "Redemption Price". The Redemption Price
         shall be adjusted in the event of any subdivision, redivision,
         reduction, combination or consolidation of the outstanding Series 1
         Shares to provide that the Series 1 Holders shall thereafter be
         entitled to receive the same amount in respect of the Redemption Price
         as they would have been entitled to receive had the Corporation
         redeemed the Series 1 Shares prior to the occurrence of any such event.

4.2      PARTIAL REDEMPTION

         If less than all the Series 1 Shares are at any time to be redeemed,

the shares to be redeemed shall be selected by lot or in such other manner as the board of directors may deem equitable or, if the board of directors so determines, on a pro rata basis, disregarding fractions, according to the number of Series 1 Shares held by each of the registered holders thereof. If less than all of the Series 1 Shares are at any time to be redeemed and a Series 1 Holder has duly exercised his right to convert into Common Shares all or any part of the number of Series 1 Shares held by such holder which have been called for redemption, the number of Series 1 Shares held by such Series 1 Holder to be redeemed shall be reduced by the number (but not exceeding the number of Series 1 Shares held by such Series 1 Holder called for redemption) of Series 1 Shares in respect of which such registered holder has duly exercised his right to convert


8

into Common Shares. If only a part of the Series 1 Shares represented by any certificate shall be redeemed, a new certificate representing the balance of such shares shall be issued to the holder thereof at the expense of the Corporation upon presentation and surrender of the first mentioned certificate.

4.3 METHOD OF REDEMPTION

4.3.1    In any case of redemption of Series 1 Shares, the Corporation shall not
         less than 10 days and not more than 45 days before the date specified
         for redemption send by prepaid first class mail or deliver to the
         registered address of each person who at the date not more than 50 days
         prior to the date of mailing or delivery is a Series 1 Holder to be
         redeemed a notice in writing of the intention of the Corporation to
         redeem the Series 1 Shares registered in the name of such holder.
         Accidental failure or omission to give such notice to one or more
         holders shall not affect the validity of such redemption, but upon such
         failure or omission being discovered notice shall be given forthwith to
         such holder or holders and such notice shall have the same force and
         effect as if given in due time. Such notice shall set out the number of
         Series 1 Shares held by the person to whom it is addressed which are to
         be redeemed, the Redemption Price, the that specified for redemption
         and the place or places at which holders of Series 1 Shares may present
         and surrender such shares for redemption.

4.3.2    On the date so specified for redemption, the Corporation shall pay or
         cause to be paid to or to the order of the Series 1 Holders to be
         redeemed the Redemption Price of such shares on presentation and
         surrender of the certificate or certificates representing the Series 1
         Shares called for redemption at the registered office of the
         Corporation or any other place or places specified in the notice of
         redemption. Payment in respect of Series 1 Shares being redeemed shall
         be made by check payable to the holder thereof in lawful money of the
         United States at par at any branch in the United States of the
         Corporation's bankers for the time being.

4.3.3    From and after the date specified for redemption in any such notice of
         redemption, the Series 1 Shares called for redemption shall cease to be
         entitled to dividends or any other participation in the assets of the
         Corporation and the holders thereof shall not be entitled to exercise
         any of their other rights as shareholders in respect thereof unless
         payment of the Redemption Price shall not be made upon presentation and
         surrender of the certificates in accordance with the foregoing
         provisions, in which case the rights of the holders shall remain
         unaffected.

4.3.4    The Corporation shall have the right at any time on or after the
         mailing or delivery of notice of its intention to redeem Series 1
         Shares to deposit the Redemption Price of the Series 1 Shares so called
         for redemption, or of such of the Series 1 Shares which are represented
         by certificates which have not at the date of such deposit been
         surrendered by the holders thereof in connection with such redemption,
         to a special account in any specified United States bank named in such
         notice of redemption or in a subsequent notice to the registered
         holders of the shares in respect of which the deposit is made, to be
         paid without interest to or to the order of the respective Series 1
         Holders whose shares


9

         have been called for redemption, upon presentation and surrender to
         such bank of the certificates representing such shares. Upon such
         deposit being made, the Series 1 Shares in respect of which such
         deposit shall have been made shall be deemed to have been redeemed and
         the rights of the holders thereof after such shall be limited to
         receiving their proportion (less any tax required to be deducted or
         withheld therefrom) of the amount so deposited without interest upon
         presentation and surrender of the certificate or certificates
         representing the Series 1 Shares being redeemed. Any interest allowed
         on any such deposit shall belong to the Corporation.

4.3.5    Redemption moneys that are represented by a check which has not been
         presented to the Corporation's bankers for payment or that otherwise
         remain unclaimed (including moneys held on deposit in a special account
         as provided for above) for a period of 5 years from the date specified
         for redemption shall be forfeited to the Corporation.

5.       RESTRICTIONS ON DIVIDENDS, RETIREMENT AND ISSUANCE OF SHARES

         While any Series 1 Shares are outstanding, the Corporation shall not,

without the approval of the holders of Series 1 Shares given as hereinafter specified:

(a) declare, set aside for payment or pay any dividends on or make distributions on or in respect of any Junior Shares (other than dividends consisting of Junior Shares); or

(b) call for redemption, redeem, purchase, retire or acquire for value or distribute in respect of any Junior Shares (except to the extent and out of net cash proceeds received by the Corporation from a substantially concurrent issue of Junior Shares); or

(c) call for redemption, redeem. purchase or otherwise retire or acquire for value less than all of the Series 1 Shares outstanding;

unless, in each such case, all dividends then payable on the Series 1 Shares then outstanding accrued up to and including the dividends payable on the immediately preceding respective date or dates for the payment of dividends thereon shall have been declared and paid or set apart for payment or unless such action has been approved by the Series 1 Holders.

6. LIQUIDATION, DISSOLUTION OR WINDING-UP

In the event of any Liquidation Distribution, each Series 1 Holder shall be entitled to receive before any amount shall be paid by the Corporation or any assets of the Corporation shall be distributed to registered holders of shares ranking as to capital junior to the Series 1 Shares in connection with the Liquidation Distribution, an amount equal to the stated capital per share of all Series 1 Shares held by such holder, together with an amount equal to all accrued but unpaid cumulative dividends thereon. After payment to the Series 1 Holders of the amount so payable to them, they shall not be entitled to share in any further distribution of assets of the Corporation.


10

7. VOTING RIGHTS

Except as otherwise required by law, the holders of the Series 1 Shares shall not be entitled, as such, to receive notice of or attend or vote at any meeting of shareholders of the Corporation other than a meeting of Series 1 Holders.

8. AMENDMENTS TO SERIES 1 PROVISIONS

These Series 1 Provisions may be repealed, altered, modified, amended or varied only with the prior approval of the holders of the Series 1 Shares given in the manner provided in Section 9 hereof in addition to any other approval required by any statutory provision of like or similar effect applicable to the Corporation from tie to time in force.

9. CONSENTS AND APPROVALS

9.1 The approval of the Series 1 Holders with respect to any and all matters may be given by one or more consents in writing signed by the holders of at least 2/3 of the issued and outstanding Series 1 Shares or by a resolution passed by at least 2/3 of the votes cast at a meeting of the Series 1 Holders duly called for that purpose and held upon at least 10 days' notice, at which the holders of at least 1/3 of the outstanding Series 1 Shares are present or represented by proxy. If at any such meeting the holders of 1/3 of the outstanding Series 1 Shares are not present or represented by proxy within one-half hour after the time appointed for such meeting, then the meeting may be adjourned to such date being not less than 7 days later and to such time and place as may be appointed by the chairman of the meeting.

9.2 The formalities to be observed with respect to the giving of notice of any such meeting and the conduct thereof shall be those from time to time prescribed by the by-laws of the Corporation with respect to meetings of shareholders.

9.3 On every vote taken at every such meeting or adjourned meeting every Series 1 Holder shall be entitled to one vote in respect of each Series 1 Share of which he is the registered holder.

10. NOTICES

10.1 Any notice required or permitted to be given to any Series 1 Holder shall be sent by first class mail, postage prepaid, or delivered to such holder at his address as it appears on the records of the Corporation or, in the event of the address of any such shareholder not so appearing, to the last known address of such shareholder. The accidental failure to give notice to one or more of such shareholders shall not affect the validity of any action requiring the giving of notice by the Corporation. Any notice given as aforesaid shall be deemed to be given on the date upon which It is mailed or delivered.


CERTIFICATE OF DESIGNATIONS
ICHOR CORPORATION

ICHOR Corporation, a Delaware corporation (the "Corporation"), desires to designate the rights and preferences of a series of preferred stock (the "Series 2 Preferred Stock") in accordance with the Corporation's Certificate of Incorporation and Section 151 of the Delaware General Corporation Law. Roy Zanatta, Director of the Corporation, hereby certifies the following:

1. This Certificate is the act and deed of Roy Zanatta, Director of the Corporation. The facts stated in this Certificate are true.

2. The resolutions attached as Exhibit A were duly adopted by the board of directors effective November 30, 1999.

3. The number of shares of Series 2 Preferred Stock to which the resolutions at Exhibit A apply is 100,000 shares.

DATED December 6, 1999.

/s/ ROY ZANATTA
--------------------------
Roy Zanatta
Director

DATED December 6, 1999.

/s/ KARIN LALANI
--------------------------
(Signature of Notary)

KARIN LALANI
(Legibly Print or Stamp Name of Notary)

Notary public in and for British Columbia,
Canada, residing at Vancouver, British
Columbia

My commission expires at the pleasure of
her majesty the Queen in the Right of the
Province of British Columbia


EXHIBIT A

DIRECTORS' RESOLUTIONS

BE IT RESOLVED THAT:

1. A second series of Preferred Stock be and is hereby designated as "5% Cumulative Redeemable Convertible Preferred Stock, Series 2" (the "Series 2 Preferred Stock").

2. The number of Series 2 Preferred Stock in the capital of the Corporation be and is hereby fixed at 100,000.

3. The Series 2 Preferred Stock shall have attached thereto the special rights and restrictions, as a series, in substantially the form set out in Schedule "A" hereto, with such changes, additions and alterations thereto as the President or Secretary may deem necessary or desirable, and that the constating documents of the Corporation be amended as necessary to incorporate same.

4. Any one director or officer of the Corporation be and is hereby authorized to execute and deliver the Certificate of Designations relating to the Series 2 Preferred Stock for and on behalf of the Corporation.


SCHEDULE "A"

The second series of Preferred Stock, designated 5% Cumulative Redeemable Convertible Preferred Stock, Series 2 (the "Series 2 Shares") shall have attached thereto, in addition to the rights, privileges, restrictions, conditions and limitations attaching to the Preferred Stock as a class, the following rights, privileges, restrictions and conditions (the "Series 2 Provisions"):

1. GENERAL

1.1 DEFINITIONS

Where used in these Series 2 Provisions, the following words and phrases shall, unless there is something in the context otherwise inconsistent therewith, have the following meanings, respectively:

(a) "business day" means a day other than a Saturday, Sunday or any other day treated as a holiday in the State of Delaware;

(b) "close of business" means the normal closing hour of the principal office of the transfer agent for the Series 2 Shares;

(c) "Common Shares" means the Common Shares in the Corporation as such shares were constituted on November 30, 1999, or as such shares may be changed from time to time, provided that any adjustment in the Conversion Rate required by clause 3.5 hereof has been made;

(d) "Conversion Price" means 90% of the Current Market Price;

(e) "Conversion Rate" means at any time the number of Common Shares into which one Series 2 Share maybe converted at such time in accordance with the provisions of Section 3;

(f) "Current Market Price" of the Common Shares on any date means the arithmetic weighted average of the closing prices for sales of Common Shares on the designated exchange based upon the 20 day average closing trading price on the designated exchange, provided that in the event that the Common Shares are not listed on any stock exchange or through any quotation system, Current Market Price shall be determined by the board of directors of the Corporation, which determination shall be conclusive;

(g) "designated exchange" means on any date, the stock exchange or quotation system through which the largest number of Common Shares of the Corporation traded over the 20 trading day period immediately preceding such date;

(h) "director" means a director of the Corporation for the time being and "directors" or "board of directors" means the board of directors of the Corporation or, if duly constituted and


2

empowered, the executive committee of the board of directors of the Corporation for the time being, and reference, without further elaboration, to action by the directors means either action by the directors of the Corporation as a board or action by the said executive committee as such committee;

(i) "herein", "hereto", "hereunder", "hereof", "hereby" and similar expressions mean or refer to these Series 2 Provisions and not to any particular Section, clause, subclause, subdivision or portion hereof, and the expressions "Section", "clause" and "subclause" followed by a number or a letter mean and refer to the specified Section, clause or subclause hereof;

(j) "Initial Issue Date" means the first date on which any Series 2 Shares are issued and outstanding;

(k) "Issue Price" means $10.00 per Series 2 Share;

(l) "Junior Shares" means any shares in the capital of the Corporation ranking after or subordinate to the Series 2 Shares as to the payment of dividends or the return of capital, including, without limiting the generality of the foregoing, the Common Shares;

(m) "Liquidation Distribution" means the distribution of assets of the Corporation on the liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary, or any other distribution of assets of the Corporation among its shareholders for the purpose of winding up its affairs;

(n) "ranking as to capital" means ranking or priority with respect to the distribution of assets in the event of a Liquidation Distribution;

(o) "Series 1 Shares" means the first series of Preferred Stock, designated 5% Cumulative Redeemable Convertible Preferred Stock, Series 1, of which 467,500 are issued and outstanding as at November 30, 1999;

(p) "Series 1 Holder" means a person recorded in the securities register of the Corporation as being the registered holder of one or more Series 1 Shares;

(o) "Series 2 Holder" means a person recorded on the securities register of the Corporation as being the registered holder of one or more Series 2 Shares;

(p) "trading day" means any day on which the designated exchange is open for business and on which the relevant class of shares of the Corporation are traded; and

(q) "transfer agent" means the corporation or corporations from time to time appointed by the directors as the transfer agent for the Series 2 Shares and, in the event that no such person is appointed, "transfer agent" means the Corporation.


3

1.2 GENDER, ETC.

Words importing only the singular number include the plural and vice versa and words importing any gender include all genders.

1.3 CURRENCY

All monetary amounts referred to herein shall be in lawful money of the United States.

1.4 HEADINGS

The division of these Series 2 Provisions into sections, clauses, subclauses or other subdivisions and the insertion of headings are for convenience of reference only and shall not affect the construction or interpretation hereof.

1.5 BUSINESS DAY

In the event that any date upon which any dividends on the Series 2 Shares are payable by the Corporation, or upon, or by which any other action is required to be taken by the Corporation or any Series 2 Holder hereunder, is not a business day, then such dividend shall be payable or such other action shall be required to be taken on or by the next succeeding day which is a business day.

2. DIVIDENDS

2.1 DECLARATION AND PAYMENT OF DIVIDENDS

The holders of Series 2 Shares shall be entitled to receive and the Corporation shall pay thereon, as and when declared by the board of directors out of funds legally available for such purpose, fixed preferential cumulative cash dividends at the rate of $0.50 per share per annum. Such dividends shall accrue, whether or not earned or declared, from and including the date of issue of such shares and, subject as hereinafter provided, shall be payable in equal quarterly installments of $0.125 per share on the last day of each of March, June, September and December in each year (each of which date is hereinafter referred to as a "dividend payment date"). The first dividend payment date shall be December 31, 1999. In the event that the Corporation does not have sufficient funds legally available for the purpose of payment of dividends to allow full payment of dividends to Series 1 Holders and Series 2 Holders on any dividend payment date, payment of dividends on such date shall be made pro rata and pari passu to the holders of the Series 1 Shares and the Series 2 Shares.


4

2.2 AMOUNT OF DIVIDEND

The amount of the dividend for any period which is less than a full quarter with respect to any Series 2 Share:

(i) which is issued, redeemed or purchased; or

(ii) where assets of the Corporation are distributed to the Series 2 Holders pursuant to Section 6 hereof;

shall be equal to the amount calculated by multiplying $0.125 by a fraction the numerator of which is the number of days in such quarter for which such share has been outstanding (including the dividend payment date at the beginning of such quarter if such share was outstanding on that date excluding the next succeeding dividend payment date if such share was outstanding on that date), and the denominator of which is the number of days in such quarter (including the dividend payment date at the beginning thereof and excluding the next succeeding dividend payment date).

The amount of dividend payable in respect of each Series 2 Share on the first dividend payment date following the Initial Issue Date shall be that proportion of $0.125 which the number of days from and including the Initial Issue Date to but excluding such dividend payment date is to the total number of days in the 3 month period immediately preceding such dividend payment date.

2.3 CUMULATION OF DIVIDENDS

If on any dividend payment date a dividend accrued to and payable on such date is not paid in full on the Series 2 Shares then issued and outstanding, the dividend or the unpaid part thereof shall be paid on a subsequent dividend payment date or dividend payment dates determined by the board of directors on which the Corporation shall have sufficient moneys legally available for the payment of the same. The Series 2 Holders shall not be entitled to any dividends other than or in excess of the fixed preferential cumulative dividends provided for in this Section 2.

3. CONVERSION

3.1 RIGHT TO CONVERT

Upon and subject to the terms and conditions hereinafter set forth, the holders of Series 2 Shares shall have the right, at any time and from time to time, up to the close of business on November 30, 2004, or, in the case of Series 2 Shares called for redemption, to the close of business on the business day immediately preceding the date fixed for redemption, whichever is earlier (provided, however, that if the Corporation shall fail to redeem such Series 2 Shares in accordance with the notice of redemption the right of conversion shall thereupon be restored as if such call for redemption had not been made), to convert all or any part of their Series 2 Shares into fully paid and non-assessable Common Shares, at the Conversion Rate in effect on the date of conversion. Unless


5

and until adjusted in accordance with these Series 2 Provisions, the Conversion Rate shall be equal to the quotient obtained when the Issue Price plus all accrued and unpaid dividends thereon outstanding as at the date of conversion is divided by the Conversion Price.

3.2 CONVERSION PROCEDURE

The conversion right provided for in clause 3.1 may be exercised by completing and executing a notice of conversion on the certificate or certificates representing the Series 2 Shares in respect: of which the holder thereof desires to exercise such right of conversion or such other form of notice approved by the Corporation and by delivering the said notice and certificate or certificates to the transfer agent for the Series 2 Shares at any office for the transfer of the Series 2 Shares. The said notice of conversion shall be signed by such holder or by his duly authorized attorney or agent, with signature guaranteed in a manner satisfactory to the transfer agent and shall specify the number of Series 2 Shares which the Series 2 Holder desires to have converted. The transfer form in the certificate or certificates in question need not be endorsed, except in the circumstances contemplated by clause 3.3. If loss than all the Series 2 Shares represented by a certificate or certificates are to be converted, the Series 2 Holder shall be entitled to receive, at the expense of the Corporation, a new certificate representing the Series 2 Shares represented by the certificate or certificates surrendered as aforesaid which are not to be converted.

3.3 PERSON TO WHOM COMMON SHARES WILL BE ISSUED

On any conversion of Series 2 Shares the share certificates for Common Shares resulting therefrom shall be issued at the expense of the Corporation in the name of the registered holder of the Series 2 Shares converted or in such name or names as such registered holder may direct in writing, provided that such registered holder shall pay any applicable security transfer taxes. In any case where the Common Shares are to be issued in the name of a person other than the holder of the converted Series 2 Shares, the transfer form on the back of the certificates in question shall be endorsed by the registered holder of the Series 2 Shares or his duly authorized attorney or agent, with signature guaranteed in a manner satisfactory to the transfer agent.

3.4 EFFECTIVE DATE OF CONVERSION

Each Series 2 Holder whose shares are to be converted in whole or in part (or any other person or persons in whose name or names any certificates representing Common Shares are issued as provided in clause 3.3) shall be deemed to have become the holder of record of the Common Shares into which such Series 2 Shares are converted, for all purposes, on the respective dates of receipt by the transfer agent of the certificate or certificates representing the Series 2 Shares to be converted as provided in clause 3.2, notwithstanding any delay in the delivery of the certificate or certificates representing the Common Shares into which such Series 2 Shares have been converted and, effective as of and throughout such respective dates, the Series 2 Holder shall cease to be registered as the holder of record of the Series 2 Shares so converted.


6

3.5 ADJUSTMENT OF CONVERSION RATE

3.5.1    If and whenever at any tine and from time to time the Corporation shall
         (i) subdivide, redivide or change its then outstanding Common Shares
         into a greater number of Common Shares, (ii) reduce, combine or
         consolidate or change its then outstanding Common Shares into a lesser
         number of Common Shares, or (iii) issue Common Shares (or securities
         exchangeable or convertible into Common Shares) to the holders of all
         or substantially all of its then outstanding Common Shares by way of
         stock dividend or other distribution (other than a stock dividend paid
         in the ordinary course) (any of such events being herein called a
         "Common Share Reorganization"), the Conversion Rate shall be adjusted
         effective immediately after the record date at which the holders of
         Common Shares are determined for the purpose of the Common Share
         Reorganization to provide that each Series 2 Holder shall thereafter be
         entitled to receive such number of Common Shares as he would have been
         entitled to receive had he exercised his conversion rights immediately
         prior to such Common Share Reorganization.

3.5.2    If and whenever there is a capital reorganization of the Corporation
         not otherwise provided for in this clause 3.5 or a consolidation,
         merger, arrangement or amalgamation (statutory or otherwise) of the
         Corporation with or into another body corporate (any such event being
         called a "Capital Reorganization"), any Series 2 Holder who has not
         exercised his right of conversion prior to the record date for such
         Capital Reorganization shall be entitled to receive and shall accept,
         upon the exercise of such right at any time after the record date for
         such Capital Reorganization, in lieu of the number of Common Shares to
         which he was theretofore entitled upon conversion, the aggregate number
         of shares or other securities of the Corporation or of the corporation
         or body corporate resulting, surviving or continuing from the Capital
         Reorganization that such holder would have been entitled to receive as
         a result of such Capital Reorganization if, on the record date, he had
         been the registered holder of the number of Common Shares to which he
         was theretofore entitled upon conversion, subject to adjustment
         thereafter in accordance with provisions the same, as nearly as may be
         possible, as those contained in this clause 3.5; provided that no such
         Capital Reorganization shall be carried into effect unless all
         necessary steps shall have been taken so that the Series 2 Holder shall
         thereafter be entitled to receive such number of shares or other
         securities of the Corporation or of the corporation or body corporate
         resulting, surviving or continuing from the Capital Reorganization.

3.5.3    In case of any reclassification of, or other change in, the outstanding
         Common Shares other than a Common Share Reorganization or a Capital
         Reorganization, the right of conversion shall be adjusted immediately
         after the record date for such reclassification or other change so that
         Series 2 Holders shall be entitled to receive, upon the exercise of
         such right at any time after the record date of such reclassification
         or other change, such shares, securities or rights as they would have
         received had such Series 2 Shares been converted into Common Shares
         immediately prior to such record date subject to adjustment thereafter
         in accordance with provisions, the same as nearly may be possible, as
         those contained in this clause 3.5.


7

3.6 ENTITLEMENT TO DIVIDENDS

Each Series 2 Holder on the record date for any dividend declared payable on the Series 2 Shares shall be entitled to such dividend notwithstanding that any Series 2 Share owned by him is converted after such record date and before the payment date of such dividend. The registered holder of any Common Share resulting from any conversion effected pursuant to this
Section 3 shall be entitled to rank equally with the registered holders of all other Common Shares in respect of all dividends declared payable to holders of Common Shares of record on or after the date of conversion.

3.7 AVOIDANCE OF FRACTIONAL SHARES

In any case where a fraction of a Common Share would otherwise be issuable on conversion of one or more Series 2 Shares, the Corporation shall, at its option, either (i) adjust such fractional interest by payment by check in an amount equal to the then current market value of such fractional interest or
(ii) issue in respect of such fraction a scrip certificate transferable by delivery entitling the holder thereof and of other similar certificates aggregating one full Common Share, upon surrender of such certificates at such place as may be designated therein, to obtain from the Corporation a full Common Share and to receive a share certificate therefor; such checks shall be payable to the holders thereof in lawful money of the United States at par at any branch in the United States of the Corporation's bankers for the time being and such scrip certificates shall be in such form and shall be subject to such terms and conditions as the directors may determine and shall provide that the holder thereof shall not thereby be a shareholder and shall not be entitled to receive dividends or to any other rights of a shareholder. The amount of any cash adjustment shall equal the current market value of such fractional interest computed on. the basis of the last sale price (or avenge of the bid and asked prices if there were no sales) per share for the Common Shares on the NASDAQ Stock Market (or, if such shares are not then listed and posted for trading on such stock exchange, on such stock exchange or quotation system through which such shares are listed and posted for trading as may be selected by the board of directors) on the business day next preceding the conversion date. In the event that the Common Shares of the Corporation are not listed on any stock exchange or through any quotation system the current market value shall be determined by the board of directors which determination shall be conclusive.

4. REDEMPTION

4.1 OPTIONAL REDEMPTION

4.1.1    The Corporation, upon giving notice as hereinafter provided, may redeem
         all at any time and part from time to time of the then outstanding
         Series 2 Shares, on payment for each share to be redeemed of the Issue
         Price together in each ease with an amount equal to all accrued and
         unpaid cumulative preferential dividends thereon calculated to but
         excluding the date fixed for redemption, the whole constituting and
         herein referred to as the "Redemption Price". The


8

Redemption Price shall be adjusted in the event of any subdivision, redivision, reduction, combination or consolidation of the outstanding Series 2 Shares to provide that the Series 2 Holders shall thereafter be entitled to receive the same amount in respect of the Redemption Price as they would have been entitled to receive had the Corporation redeemed the Series 2 Shares prior to the occurrence of any such event.

4.2 PARTIAL REDEMPTION

If less than all the Series 2 Shares are at any time to be redeemed, the shares to be redeemed shall be selected by lot or in such other manner as the board of directors may deem equitable or, if the board of directors so determines, on a pro rata basis, disregarding fractions, according to the number of Series 2 Shares held by each of the registered holders thereof. If less than all of the Series 2 Shares are at any time to be redeemed and a Series 2 Holder has duly exercised his right to convert into Common Shares all or any part of the number of Series 2 Shares held by such holder which have been called for redemption, the number of Series 2 Shares held by such Series 2 Holder to be redeemed shall be reduced by the number (but not exceeding the number of Series 2 Shares held by such Series 2 Holder called for redemption) of Series 2 Shares in respect of which such registered holder has duly exercised his right to convert into Common Shares. If only a part of the Series 2 Shares represented by any certificate shall be redeemed, a new certificate representing the balance of such shares shall be issued to the holder thereof at the expense of the Corporation upon presentation and surrender of the first mentioned certificate.

4.3 METHOD OF REDEMPTION

4.3.1    In any case of redemption of Series 2 Shares, the Corporation shall not
         less than 10 days and not more than 45 days before the date specified
         for redemption send by prepaid first class mail or deliver to the
         registered address of each person who at the date not more than 50 days
         prior to the date of mailing or delivery is a Series 2 Holder to be
         redeemed a notice in writing of the intention of the Corporation to
         redeem the Series 2 Shares registered in the name of such holder.
         Accidental failure or omission to give such notice to one or more
         holders shall not affect the validity of such redemption, but upon such
         failure or omission being discovered notice shall be given forthwith to
         such holder or holders and such notice shall have the same force and
         effect as if given in due time. Such notice shall set out the number of
         Series 2 Shares held by the person to whom it is addressed which are to
         be redeemed, the Redemption Price, the date specified for redemption
         and the place or places at which holders of Series 2 Shares may present
         and surrender such shares for redemption.

4.3.2    On the date so specified for redemption, the Corporation shall pay or
         cause to be paid to or to the order of the Series 2 Holders to be
         redeemed the Redemption Price of such shares on presentation and
         surrender of the certificate or certificates representing the Series 2
         Shares called for redemption at the registered office of' the
         Corporation or any other place or places specified in the notice of
         redemption. Payment in respect of Series 2 Shares being redeemed


9

         shall be made by check payable to the holder thereof in lawful money of
         the United States at par at any branch in the United States of the
         Corporation's bankers for the time being.

4.3.3    From and after the date specified for redemption in any such notice of
         redemption, the Series 2 Shares called for redemption shall cease to be
         entitled to dividends or any other participation in the assets of the
         Corporation and the holders thereof shall not be entitled to exercise
         any of their other rights as shareholders in respect thereof unless
         payment of the Redemption Price shall not be made upon presentation and
         surrender of the certificates in accordance with the foregoing
         provisions, in which case the rights of the holders shall remain
         unaffected.

4.3.4    The Corporation shall have the right at any time on or after the
         mailing or delivery of notice of its intention to redeem Series 2
         Shares to deposit the Redemption Price of the Series 2 Shares so called
         for redemption, or of such of the Series 2 Shares which are represented
         by certificates which have not at the date of such deposit been
         surrendered by the holders thereof in connection with such redemption,
         to a special account in any specified United States bank named in such
         notice of redemption or in a subsequent notice to the registered
         holders of the shares in respect of which the deposit is made, to be
         paid without interest to or to the order of the respective Series 2
         Holders whose shares have been called for redemption, upon presentation
         and surrender to such bank of the certificates representing such
         shares. Upon such deposit being made, the Series 2 Shares in respect of
         which such deposit shall have been made shall be deemed to have been
         redeemed and the rights of the holders thereof after such shall be
         limited to receiving their proportion (less any tax required to be
         deducted or withheld therefrom) of the amount so deposited without
         interest, upon presentation and surrender of the certificate or
         certificates representing the Series 2 Shares being redeemed. Any
         interest allowed on any such deposit shall belong to the Corporation.

4.3.5    Redemption moneys that are represented by a check which has not been
         presented to the Corporation's bankers for payment or that otherwise
         remain unclaimed (including moneys held on deposit in a special account
         as provided for above) for a period of 5 years from the date specified
         for redemption shall be forfeited to the Corporation.

5.       RESTRICTIONS ON DIVIDENDS, RETIREMENT AND ISSUANCE OF SHARES

         While any Series 2 Shares are outstanding, the Corporation shall not,

without the approval of the holders of Series 2 Shares given as hereinafter specified:

(a) declare, set aside for payment or pay any dividends on or make distributions on or in respect of any Junior Shares (other than dividends consisting of Junior Shares); or

(b) call for redemption, redeem, purchase, retire or acquire for value or distribute in respect of any Junior Shares (except to the extent and out of net cash proceeds received by the Corporation from a substantially concurrent issue of Junior Shares); or


10

(c) call for redemption, redeem, purchase or otherwise retire or acquire for value less than all of the Series 2 Shares outstanding;

unless, in each such case, all dividends then payable on the Series 2 Shares then outstanding accrued up to and including the dividends payable on the immediately preceding respective date or dates for the payment of dividends thereon shall have been declared and paid or set apart for payment or unless such action has been approved by the Series 2 Holders.

6. LIQUIDATION, DISSOLUTION OR WINDING-UP

In the event of any Liquidation Distribution, each Series 2 Holder shall be entitled to receive before any amount shall be paid by the Corporation or any assets of the Corporation shall be distributed to registered holders of shares ranking as to capital junior to the Series 2 Shares in connection with the Liquidation Distribution, an amount equal to the stated capital per share of all Series 2 Shares held by such holder, together with an amount equal to all accrued but unpaid cumulative dividends thereon. After payment to the Series 2 Holders of the amount so payable to them, they shall not be entitled to share in any further distribution of assets of the Corporation.

7. VOTING RIGHTS

Except as otherwise required by law, the holders of the Series 2 Shares shall not be entitled, as such, to receive notice of or attend or vote at any meeting of shareholders of the Corporation other than a meeting of Series 2 Holders.

8. AMENDMENTS TO SERIES 1 PROVISIONS

These Series 2 Provisions may be repealed, altered, modified, amended or varied only with the prior approval of the holders of the Series 2 Shares given in the manner provided in Section 9 hereof in addition to any other approval required by any statutory provision of like or similar effect applicable to the Corporation, from time to time in force.

9. CONSENTS AND APPROVALS

9.1 The approval of the Series 2 Holders with respect to any and all matters may be given by one or more consents in writing signed by the holders of at least 2/3 of the issued and outstanding Series 2 Shares or by a resolution passed by at least 2/3 of the votes cast at a meeting of the Series 2 Holders duly called for that purpose and held upon at least 10 days' notice, at which the holders of at least 1/3 of the outstanding Series 2 Shares are present or represented by proxy. If at any such meeting the holders of 1/3 of the outstanding Series 2 Shares are not present or represented by proxy within one-half hour after the time appointed for such meeting, then the meeting may be adjourned to such date being not less than 7 days later and to such time and place as may be appointed by the chairman of the meeting.


11

9.2 The formalities to be observed with respect to the giving of notice of any such meeting and the conduct thereof shall be those from time to time prescribed by the by-laws of the Corporation with respect to meetings of shareholders.

9.3 On every vote taken at every such meeting or adjourned meeting every Series 2 Holder shall be entitled to one vote in respect of each Series 2 Share of which he is the registered holder.

10. NOTICES

10.1 Any notice required or permitted to be given to any Series 2 Holder shall be sent by first class mail, postage prepaid, or delivered to such holder at his address as it appears on the records of the Corporation or, in the event of the address of any such shareholder not so appearing, to the last known address of such shareholder. The accidental failure to give notice to one or more of such shareholders shall not affect the validity of any action requiring the giving of notice by the Corporation. Any notice given as aforesaid shall be deemed to be given on the date upon which it is mailed or delivered.


CERTIFICATE OF DESIGNATIONS
ICHOR CORPORATION

ICHOR Corporation, a Delaware corporation (the "Corporation"), desires to designate the rights and preferences of a series of preferred stock (the "Special Voting Preferred Stock") in accordance with the Corporation's Certificate of Incorporation and Section 151 of the Delaware General Corporation Law. Jin-Soo Choi, the President and a Director of the Corporation, hereby certifies the following:

1. This Certificate is the act and deed of Jin-Soo Choi, the President and a Director of the Corporation. The facts stated in this Certificate are true.

2. The resolutions attached as Exhibit A were duly adopted by the Board of Directors of the Corporation effective March 19, 2001.

3. The number of shares of Special Voting Preferred Stock to which the resolutions at Exhibit A apply is one (1) share.

DATED March 19, 2001.

/s/ Jin-Soo Choi
-------------------------
Jin-Soo Choi
President and Director


EXHIBIT A

DIRECTORS' RESOLUTIONS

BE IT RESOLVED THAT:

1. A series of Preferred Stock be and is hereby designated as "Special Voting Preferred Stock" (the "Special Voting Preferred Stock").

2. The number of Special Voting Preferred Stock in the capital of the Corporation be and is hereby fixed at one (1).

3. The Special Voting Preferred Stock shall have attached thereto the special rights and restrictions, as a series, in substantially the form set out in Schedule "A" hereto, with such changes, additions and alterations thereto as any one director or officer of the Corporation may deem necessary or desirable, and that the constating documents of the Corporation be amended as necessary to incorporate same.

4. Any one director or officer of the Corporation be and is hereby authorized to execute and deliver the Certificate of Designations relating to the Special Voting Preferred Stock for and on behalf of the Corporation.


SCHEDULE "A"

A series of Preferred Stock, designated Special Voting Preferred Stock (the "Special Voting Preferred Share") shall have attached thereto, in addition to the rights, privileges, restrictions, conditions and limitations attaching to the Preferred Stock as a class, the following rights, privileges, restrictions and conditions:

1. NUMBER OF SHARES. There shall be one Special Voting Preferred Share.

2. DIVIDENDS OR DISTRIBUTIONS. Neither the holder nor, if different, the owner of the Special Voting Preferred Share shall be entitled to receive dividends or distributions in its capacity as holder or owner thereof.

3. VOTING RIGHTS. Except as provided in section 4 below, the holder of the Special Voting Preferred Share shall have the following voting rights:

(a) The holder of the Special Voting Preferred Share shall be entitled to vote on each matter on which holders of the shares (the "Common Shares") of common stock of ICHOR Corporation (the "Corporation"), $0.01 par value per share or stockholders generally are entitled to vote, and the holder of the Special Voting Preferred Share shall be entitled to cast on each such matter a number of votes equal to the number of exchangeable preferential non voting shares of class B of 6543 Luxembourg S.A. (the "Exchangeable Preferred Shares") then outstanding:

(i) that are not owned by the Corporation or its affiliates; and

(ii) as to which the holder of the Special Voting Preferred Share has duly and timely received voting instructions from the holders of such Exchangeable Preferred Shares in accordance with the terms of such Exchangeable Preferred Shares or any agreement governing the provision of voting instructions to the holder of the Special Voting Preferred Share,

multiplied by 1,066.44, subject to adjustment by as determined by the board of directors of LuxCo as a result of

(iii) the subdivision, redivision or change of the then outstanding Common Shares into a greater number of Common Shares;

(iv) the reduction, combination or change of the then outstanding Common Shares into a lesser number of Common Shares; or

(v) the reclassification or other change of the Common Shares or the effectuation of an amalgamation, merger, reorganization or other transaction affecting the Common Shares; and


(b) Except as otherwise provided herein or by applicable law, the holder of the Special Voting Preferred Share and the holders of Common Shares shall vote together as one class for the election of directors of the Corporation and on all other matters submitted to a vote of stockholders of the Corporation.

4. LIQUIDATION RIGHTS. In the event of voluntary or involuntary liquidation, dissolution or winding up of the Corporation, the holder of the Special Voting Preferred Share shall be entitled to receive out of the assets of the Corporation available for distribution to the stockholders, an amount equal to $1.00 before any distribution is made on the Common Shares or any other stock ranking junior to the Special Voting Preferred Share as to distribution of assets upon voluntary or involuntary liquidation. After payment of the full amount of the liquidation preference of the Special Voting Preferred Share, the holder of the Special Voting Preferred Share shall not be entitled to any further participation in any distribution of assets of the Corporation.

For the purposes of this section 4, neither the sale, conveyance, exchange or transfer (for cash, shares of stock, securities or other consideration) of all or substantially all of the property or assets of the Corporation nor the consolidation or merger of the Corporation with or into one or more other entities shall be deemed to be a voluntary or involuntary liquidation.

5. NO REDEMPTION; NO SINKING FUND. The Special Voting Preferred Share shall not be subject to redemption by the Corporation or at the option of its holder, except that at such time as no Exchangeable Preferred Shares (other than Exchangeable Preferred Shares owned by the Corporation or its affiliates) shall be outstanding, the Special Voting Preferred Share shall automatically be redeemed and cancelled, with an amount of $1.00 due and payable upon such redemption.

The Special Voting Preferred Share shall not be subject to or entitled to the operation of a retirement or sinking fund.

6. RANKING. The Special Voting Preferred Share shall rank senior to all series of Common Shares of the Corporation and junior to all series of Preferred Stock of the Corporation.

7. RESTRICTIONS. During the term of the Voting Agreement, no term of the Special Voting Preferred Share shall be amended, except upon approval of the holder of the Special Voting Preferred Share.


CERTIFICATE OF AMENDMENT
OF CERTIFICATE OF INCORPORATION
OF ICHOR CORPORATION,
A DELAWARE CORPORATION

ICHOR CORPORATION (the "Corporation"), a corporation organized and existing under the General Corporation Law of the State of Delaware (the "General Corporation Law")

DOES HEREBY CERTIFY:

FIRST: That the name of the Corporation is ICHOR CORPORATION, and that the Corporation was incorporated pursuant to the General Corporation Law on September 16, 1996.

SECOND: That on January 19, 2001, the Board of Directors duly adopted resolutions proposing to amend the Certificate of Incorporation of the Corporation and, by written consent in accordance with Section 228 of the General Corporation Law, stockholders of the Corporation holding the requisite number of shares of the Corporation consented to the resolutions setting forth the proposed amendment, which resolutions are as follows:

RESOLVED THAT paragraph 4 of the Certificate of Incorporation of the Corporation be, and is hereby, amended to read as follows:

"4. The total number of shares of all classes of stock which the Corporation shall have authority to issue is Eighty-Five Million (85,000,000) shares, of which Five Million (5,000,000) shares shall be preferred stock, $.0l par value, and Eighty Million (80,000,000) shares shall be common stock, $.01 par value. The preferred stock of the Corporation may be issued from time to time in one or more series. The Board of Directors is expressly authorized, in a resolution or resolutions providing for the issue of such preferred stock, to fix, state and express the powers, rights, designations, preferences, qualifications, limitations and restrictions thereof and to fix the number of shares of such series.

Except as otherwise provided by law, the shares of stock of the Corporation, regardless of class, may be issued by the Corporation from time to time in such amounts, for such consideration and for such corporate purposes as the Corporation's Board of Directors may from time to time determine."

THIRD: That the said amendment was duly adopted on May 21, 2001 in accordance with the provisions of Section 242 of the General Corporation Law.

IN WITNESS WHEREOF, this Certificate of Amendment of Certificate of Incorporation has been signed by the President of the Corporation as of May 21, 2001.

By:      /s/ Pierre-Francois Serres
         -----------------------------
         Pierre-Francois Serres, President


CERTIFICATE OF AMENDMENT
OF
CERTIFICATE OF INCORPORATION

*****

ICHOR CORPORATION, a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, DOES HEREBY CERTIFY:

FIRST: That the Board of Directors of said corporation, by unanimous written consent of its members, filed with the minutes of the board adopted a resolution proposing and declaring advisable the following amendment to the Certificate of Incorporation of said corporation:

RESOLVED, that Article FIRST of the Certificate of Incorporation of ICHOR CORPORATION be amended to read as follows:

FIRST: The name of the corporation is MYMETICS CORPORATION.

SECOND: That in lieu of a meeting and vote of stockholders, the stockholders have given written consent to said amendment in accordance with the provisions of section 228 of the General Corporation Law of the State of Delaware and written notice of the adoption of the amendment has been given as provided in Section 228 of the General Corporation Law of the State of Delaware to every stockholder entitled to such notice.

THIRD: That the aforesaid amendment was duly adopted in accordance with the applicable provisions of sections 242 and 228 of the General Corporation Law of the State of Delaware.

IN WITNESS WHEREOF, said ICHOR CORPORATION has caused this certificate to be signed by its Secretary this 23rd day of July, 2001.

ICHOR CORPORATION

By       /s/ John M. Musacchio
       ----------------------------
Title:   Secretary


CERTIFICATE OF CORRECTION OF
CERTIFICATE OF AMENDMENT
OF
MYMETICS CORPORATION

It is hereby certified that:

1. The name of the corporation (hereinafter called the "corporation") is Mymetics Corporation.

2. The Certificate of Amendment of the corporation, which was filed by the Secretary of State of Delaware on July 23, 2001, is hereby corrected.

3. The inaccuracy to be corrected in said instrument is as follows:

Articles SECOND and THIRD incorrectly indicated that the stockholders gave written consent approval to said amendment in accordance with Section 228 of the General Corporation Law of the State of Delaware.

4. The portion of the instrument in corrected form is as follows:

o SECOND: That thereafter, pursuant to resolution of its. Board of Directors, the annual meeting of the stockholders of said corporation was duly called and held, upon notice in accordance with Section 222 of the General Corporation Law of the State of Delaware at which meeting the necessary number of shares as required by statute were voted in favor of the amendment.

o THIRD: That said amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

Signed on July 25, 2001                       /s/ John M. Musacchio
                                              -----------------------------
                                              John M. Musacchio, Secretary


Exhibit 3(ii)

B Y L A W S
OF
ICHOR CORPORATION
(a Delaware Corporation)

ARTICLE I

Registered Agent, Offices and Fiscal Year

Section 1.01. Registered Agent; Registered Office. - The registered agent of the corporation in the State of Delaware shall be The Corporation Trust Company, and registered office of the corporation in the State of Delaware shall be at 1209 Orange Street, Wilmington, New Castle County, Delaware 19801, until otherwise changed by an amendment to the Certificate of Incorporation (the "Certificate") or by the board of directors and a record of such change is filed with the Delaware Department of State in the manner provided by law.

Section 1.02. Other Offices. - The corporation may also have offices at such other places within or without the State of Delaware as the board of directors may from time to time determine or the business of the corporation may require.

Section 1.03. Fiscal Year. - The fiscal year of the corporation shall begin on the first day of January in each year.

ARTICLE II
Notice - Waivers - Meetings Generally

Section 2.01. Manner of Giving Notice.

(a) General Rule. - Whenever written notice is required to be given to any person under the provisions of the Delaware General Corporation Law or by the Certificate or these bylaws, it may be given to the person either personally or by sending a copy thereof by first class or express mail, postage prepaid, or by telegram (with messenger service specified), telex or TWX (with answerback received) or courier service, charges prepaid, or by facsimile transmission, to the address (or to the telex, TWX, facsimile or telephone number) of the person appearing on the books of the corporation or, in the case of directors, supplied by the director to the corporation for the purpose of notice. If the notice is sent by mail, telegraph or courier service, it shall be deemed to have been given to the person entitled thereto when deposited in the United States mail or with a telegraph office or courier service for delivery to that person or, in the case of telex, TWX or facsimile transmission, when dispatched or transmitted. A notice of meeting shall specify the place, date and hour of the meeting and any other information required by any other provision of the Delaware General Corporation Law, the Certificate or these bylaws.

(b) Bulk Mail. - If the corporation has more than 30 stockholders, notice of any regular or special meeting of the stockholders, or any other notice required by the Delaware General Corporation Law or by the Certificate or these bylaws to be given to all stockholders or to all holders of a class or series of shares, may be given by any class of postpaid mail if the notice is deposited in the United States mail at least twenty (20) days prior to the day named for the meeting for any corporate or stockholder action specified in the notice.


(c) Adjourned Stockholder Meetings. - When a meeting of stockholders is adjourned, it shall not be necessary to give any notice of the adjourned meeting or of the business to be transacted at an adjourned meeting, other than by announcement of the time and place thereof at the meeting at which the adjournment is taken. If the adjournment is for more than 30 days, or if the board fixes a new record date for the adjourned meeting, notice of the adjourned meeting shall be given in accordance with Section 2.03 of these bylaws.

Section 2.02. Notice of Meetings of Board of Directors. - Notice of a regular meeting of the board of directors need not be given. Notice of every special meeting of the board of directors shall be given to each director by telephone or in person or in writing at least twenty-four (24) hours (in the case of notice by telephone, telex, TWX or facsimile transmission) or forty-eight (48) hours (in the case of notice by telegraph, courier service or express mail) or five (5) days (in the case of notice by first class mail) before the time at which the meeting is to be held. Every such notice shall state the time and place of the meeting. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the board need be specified in a notice of the meeting.

Section 2.03. Notice of Meetings of Stockholders.

(a) General Rule. - Except as otherwise provided in Section 2.01(b) hereof, written notice of every meeting of the stockholders shall be given by, or at the direction of, the Secretary or other authorized person to each stockholder of record entitled to vote at the meeting at not less than ten (10) nor more than sixty (60) days prior to the day named for a meeting. If the Secretary neglects or refuses to give notice of a meeting, the person or persons calling the meeting may do so. In the case of a special meeting of stockholders, the notice shall specify the purpose or purposes for which the meeting is called.

Section 2.04. Waiver of Notice.

(a) Written Waiver. - Whenever any notice is required to be given under the provisions of the Delaware General Corporation Law, the Certificate or these bylaws, a written waiver thereof, signed by the person or persons entitled to the notice, whether before or after the time stated therein, shall be deemed equivalent to the notice. Neither the business to be transacted at, nor the purpose of, a meeting need be specified in the waiver of notice of the meeting.

(b) Waiver by Attendance. - Attendance of a person at any meeting shall constitute a waiver of notice of the meeting except where a person attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting was not lawfully called or convened.

Section 2.05. Modification of Proposal Contained in Notice. - Whenever the language of a proposed resolution is included in a written notice of a meeting required to be given under the provisions of the Delaware General Corporation Law or the Certificate or these bylaws, the meeting considering the resolution may without further notice adopt it with such clarifying or other amendments as do not enlarge its original purpose.

Section 2.06. Exception to Requirement of Notice.

(a) General Rule. - Whenever any notice or communication is required to be given to any person under the provisions of the Delaware General Corporation Law or by the Certificate or these bylaws or by the terms of any agreement or other instrument or as a condition precedent to taking any

-2-

corporate action and communication with that person is then unlawful, the giving of the notice or communication to that person shall not be required.

(b) Stockholders Without Forwarding Addresses. - Notice or other communications need not be sent to any stockholder with whom the corporation has been unable to communicate for more than twenty-four (24) consecutive months because communications to the stockholder are returned unclaimed or the stockholder has otherwise failed to provide the corporation with a current address. Whenever the stockholder provides the corporation with a current address, the corporation shall commence sending notices and other communications to the stockholder in the same manner as to other stockholders.

Section 2.07. Use of Conference Telephone and Similar Equipment. - Any director may participate in any meeting of the board of directors, and the board of directors may provide by resolution with respect to a specific meeting or with respect to a class of meetings that one or more persons may participate in a meeting of the stockholders of the corporation, by means of conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other. Participation in a meeting pursuant to this section shall constitute presence in person at the meeting.

ARTICLE III

Stockholders

Section 3.01. Place of Meeting. - All meetings of the stockholders of the corporation shall be held at such place, either within or outside of the State of Delaware, as may be designated by the board of directors in the notice of a meeting.

Section 3.02. Annual Meeting. - The board of directors may fix and designate the date and time of the annual meeting of the stockholders, but if no such date and time is fixed and designated by the board, the meeting for any calendar year shall be held on the third Thursday in July in such year, if not a legal holiday under the laws of the jurisdiction in which the corporation's principal office is located, and, if a legal holiday, then on the next succeeding business day, at 10:00 o'clock A.M., and at said meeting the stockholders then entitled to vote shall elect directors and shall transact such other business as may properly be brought before the meeting. If there be a failure to hold the annual meeting for a period of 30 days after the date designated therefor, or if no date has been designated, for a period of thirteen months after the last annual meeting of the corporation, the Court of Chancery may summarily order a meeting to be held upon the application of any stockholder or director.

Section 3.03. Special Meetings. - Special meetings of the stockholders may be called at any time by resolution of the board of directors, which may fix the date, time and place of the meeting. If the board does not fix the date, time or place of the meeting, it shall be the duty of the Secretary to do so. A date fixed by the secretary shall not be more than 60 days after the date of the adoption of the resolution of the board calling the special meeting.

Section 3.04. Quorum and Adjournment.

(a) General Rule. - A meeting of stockholders of the corporation duly called shall not be organized for the transaction of business unless a quorum is present. The presence, in person or by proxy, of stockholders entitled to cast at least a majority of the votes that all stockholders are entitled to cast on a particular matter to be acted upon at the meeting shall constitute a quorum for the purposes of consideration and action on the matter. Shares of the corporation owned, directly or indirectly, by it shall not be counted in determining the total number of outstanding shares for quorum purposes at any given time.

-3-

(b) Withdrawal of a Quorum. - The stockholders present at a duly organized meeting can continue to do business until adjournment notwithstanding the withdrawal of enough stockholders to leave less than a quorum.

(c) Adjournments Generally. - Any regular or special meeting of the stockholders, including one at which directors are to be elected and one which cannot be organized because a quorum has not attended, may be adjourned for such period and to such place as the stockholders present and entitled to vote shall direct.

(d) Electing Directors at Adjourned Meeting. - Those stockholders entitled to vote who attend a meeting called for the election of directors that has been previously adjourned for lack of a quorum, although less than a quorum as fixed in this section, shall nevertheless constitute a quorum for the purpose of electing directors.

(e) Other Action in Absence of Quorum. - Those stockholders entitled to vote who attend a meeting of stockholders that has been previously adjourned for one or more periods aggregating at least fifteen (15) days because of an absence of a quorum, although less than a quorum as fixed in this section, shall nevertheless constitute a quorum for the purpose of acting upon any matter set forth in the notice of the meeting if the notice states that those stockholders who attend the adjourned meeting shall nevertheless constitute a quorum for the purpose of acting upon the matter.

Section 3.05. Action by Stockholders - Except as otherwise provided in the Delaware General Corporation Law or the Certificate or these bylaws, whenever any corporate action is to be taken by vote of the stockholders of the corporation, it shall be authorized upon receiving the affirmative vote of a majority of the votes cast by all stockholders entitled to vote thereon and, if any stockholders are entitled to vote thereon as a class, upon receiving the affirmative vote of a majority of the votes cast by the stockholders entitled to vote as a class.

Section 3.06 Organization - At every meeting of the stockholders, the Chairman of the Board, if there be one, or, in the case of vacancy in office or absence of the Chairman of the Board, one of the following persons present in the order stated: the Vice Chairman of the Board, if there be one, the President, the vice presidents in their order of rank and seniority, or a person chosen by vote of the stockholders present, shall act as chairman of the meeting. The Secretary or, in the absence of the Secretary, an assistant secretary, or, in the absence of both the Secretary and assistant secretaries, a person appointed by the chairman of the meeting, shall act as secretary of the meeting.

Section 3.07. Voting Rights of Stockholders - Unless otherwise provided in the Certificate, every stockholder of the corporation shall be entitled to one vote for every share standing in the name of the stockholder on the books of the corporation.

Section 3.08. Voting and Other Action by Proxy.

(a) General Rule. -

(1) Every stockholder entitled to vote at a meeting of stockholders or to express consent or dissent to corporate action in writing without a meeting may authorize another person to act for the stockholder by proxy.

-4-

(2) The presence of or vote or other action at a meeting of stockholders by a proxy of a stockholder shall constitute the presence of or vote or action by the stockholder.

(3) Where two or more proxies of a stockholder are present, the corporation shall, unless otherwise expressly provided in the proxy, accept as the vote of all shares represented thereby the vote cast by a majority of them and, if a majority of the proxies cannot agree whether the shares represented shall be voted or upon the manner of voting the shares, the voting of the shares shall be divided equally among those persons.

(b) Execution and Filing. - Every proxy shall be executed in writing by the stockholder or by the duly authorized attorney-in-fact of the stockholder and filed with the Secretary of the corporation. A telegram, telex, cable gram, datagram or similar transmission from a stockholder or attorney-in-fact, or a photographic, facsimile or similar reproduction of a writing executed by a stockholder or attorney-in-fact:

(1) may be treated as properly executed for purposes of this subsection; and

(2) shall be so treated if it sets forth or be submitted with information from which it can be determined that such transmission was authorized by the stockholder.

(c) Revocation. A proxy, unless coupled with an interest, shall be revocable at will, notwithstanding any other agreement or any provision in the proxy to the contrary, but the revocation of a proxy shall not be effective until written notice thereof has been given to the Secretary of the corporation. An unrevoked proxy shall not be valid after three years from the date of its execution unless a longer time is expressly provided therein. A proxy shall not be revoked by the death or incapacity of the maker unless, before the vote is counted or the authority is exercised, written notice of the death or incapacity is given to the Secretary of the corporation.

(d) Expenses - The corporation shall pay the reasonable expenses of solicitation of votes, proxies or consents of stockholders by or on behalf of the board of directors or its nominees for election to the board, including solicitation by professional proxy solicitors and otherwise.

Section 3.09. Voting by Fiduciaries and Pledgees - Shares of the corporation standing in the name of a trustee or other fiduciary and shares held by an assignee for the benefit of creditors or by a receiver may be voted by the trustee, fiduciary, assignee or receiver. A stockholder whose shares are pledged shall be entitled to vote the shares until the shares have been transferred into the name of the pledgee, or a nominee of the pledgee, but nothing in this section shall affect the validity of a proxy given to a pledgee or nominee.

Section 3.10. Voting by Joint Holders of Shares.

(a) General Rule. - Where shares of the corporation are held in the names of two or more persons, whether as joint tenants, tenants in common, as fiduciaries or otherwise:

(1) if only one votes, his or her vote binds all;

(2) if more than one vote, the act of the majority so voting binds all;

(3) if more than one vote, but the vote is evenly split on any particular matter, the voting of the shares shall be divided proportionally among the persons so voting the shares.

-5-

(b) Exception. - If there has been filed with the Secretary of the corporation a copy, certified by an attorney at law to be correct, of the relevant portions of the agreement under which the shares are held or the instrument by which the trust or estate was created or the order of court appointing them or of an order of court directing the voting of the shares, the persons specified as having such voting power in the document latest in date of operative effect so filed, and only those persons, shall be entitled to vote the shares but only in accordance therewith.

Section 3.11. Voting by Corporations.

(a) Voting by Corporate Stockholders. - Any corporation that is a stockholder of this corporation may vote at meetings of stockholders of this corporation by any of its officers or agents, or by proxy appointed by any officer or agent, unless some other person, by resolution of the board of directors of the other corporation or a provision of its articles of incorporation or bylaws (a copy of which resolution or provision is certified to be correct by one of its officers, has been filed with the Secretary of this corporation) is appointed its general or special proxy in which case that person shall be entitled to vote the shares.

(b) Controlled Shares. - Shares of this corporation owned, directly or indirectly, by it shall not be voted at any meeting and shall not be counted in determining the total number of outstanding shares for voting purposes at any given time.

Section 3.12. Determination of Stockholders of Record.

(a) Fixing Record Date. - The board of directors may fix a date prior to the date of any meeting of stockholders as a record date for the determination of the stockholders entitled to notice of, or to vote at, the meeting, which time, except in the case of an adjourned meeting, shall be not more than sixty (60) days nor less than ten (10) days prior to the date of the meeting of stockholders. Only stockholders of record on the date fixed shall be so entitled notwithstanding any transfer of shares on the books of the corporation after any record date fixed as provide in this subsection. The board of directors may similarly fix a record date for the determination of stockholders of record for any other purpose. When a determination of stockholders of record has been made as provided in this section for purposes of a meeting, the determination shall apply to any adjournment thereof unless the board fixes a new record date for the adjourned meeting.

(b) Determination When a Record Date is Not Fixed. - If a record date is not fixed:

(1) The record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given.

(2) The record date for determining stockholders for the purpose of any other lawful action shall be at the close of business on the day on which the board of directors adopts the resolution relating thereto.

(c) Certification by Nominee. - The board of directors may adopt a procedure whereby a stockholder of the corporation may certify in writing to the corporation that all or a portion of the shares registered in the name of the stockholder are held for the account of a specified person or persons. Upon receipt by the corporation of a certification complying with the procedure, the persons specified in the certification shall be deemed, for the purposes set forth in the certification, to be the holders of record of the number of shares specified in place of the stockholder making the certification.

-6-

Section 3.13. Voting Lists.

(a) General Rule. - The officer or agent having charge of the stock ledger or transfer books for shares of the corporation shall prepare and make, at least ten days before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting of stockholders, arranged in alphabetical order, with the address of and the number of shares held by each. The list shall be produced and kept open to examination of any stockholder, for any purpose germane to the meeting, during ordinary business hours, for a period of at least ten days prior to the meeting, either at a place within the city where the meeting is to be held, which place shall be specified in the notice of the meeting or, if not so specified, at the place where the meeting is to be held. The list shall also be produced and kept at the time and place of the meeting and shall be subject to the inspection of any stockholder during the whole time of the meeting.

(b) Effect of List. - Failure to comply with the requirements of this section shall not affect the validity of any action taken at a meeting prior to a demand at the meeting by any stockholder entitled to vote thereat to examine the list; however, upon the willful neglect or refusal of the directors to produce such a list at any meeting of directors, they shall be ineligible for election to any office at such meeting. The stock ledger or transfer book shall be the only evidence as to who are the stockholders entitled to examine the list, the stock ledger or transfer book or the books of the corporation, or to vote at any meeting of stockholders.

Section 3.14. Inspectors of Election.

(a) Appointment. - In advance of any meeting of stockholders of the corporation, the board of directors shall appoint one or more inspectors of election, who need not be stockholders, to act at the meeting or any adjournment thereof. If inspectors of election are not so appointed, the presiding officer of the meeting shall appoint one or more inspectors to act of election at the meeting. The number of inspectors shall be one or three. A person who is a candidate for an office to be filled at the meeting shall not act as an inspector.

(b) Vacancies. - In case any person appointed as a inspector fails to appear or fails or refuses to act, the vacancy may be filled by appointment made by the board of directors in advance of the convening of the meeting or at the meeting by the presiding officer thereof.

(c) Duties - The inspectors of election shall determine the number of shares outstanding and the voting power of each, the shares represented at the meeting, the existence of a quorum, and the authenticity, validity and effect of proxies, receive votes or ballots, hear and determine all challenges and questions in any way arising in connection with nominations by stockholders or the right to vote, count and tabulate all votes, determine the result and do such acts as may be proper to conduct the election or vote with fairness to all stockholders. The inspectors of election shall perform their duties impartially, in good faith, to the best of their ability and as expeditiously as is practical. If there are three inspectors of election, the decision, act or certificate of a majority shall be effective in all respects as the decision, act or certificate of a majority shall be effective in all respects as the decision, act or certificate of all.

(d) Report - On request of the presiding officer of the meeting or of any stockholder, the judges shall make a report in writing of any challenge or question or matter determined by them, and execute a certificate of any fact found by them. Any report or certificate made by them shall be prima facie evidence of the facts stated therein.

Section 3.15. Minors as Security Holders. - The corporation may treat a minor who holds shares or obligations of the corporation as having capacity to receive

-7-

and to empower others to receive dividends, interest, principal and other payments or distributions, to vote or express consent or dissent and to make elections and exercise rights relating to such shares or obligations unless, in the case of payments or distributions on shares, the corporate officer responsible for maintaining the list of stockholders or the transfer agent of the corporation or, in the case of payments or distributions on obligations, the Treasurer or paying agent has received written notice that the holder is a minor.

Section 3.16 Consent of Stockholders in Lieu of Meeting.

Any action required by the Delaware General Corporation Law to be taken at any annual or special meeting of stockholders of the corporation, or any action which may be taken at any annual or special meeting of the stockholders, may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, shall be signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all share entitled to vote thereon were present and voted and shall be delivered to the corporation by delivery to its registered office, its principal place of business, or an officer or agent of the corporation having custody of the book in which proceeding of meetings of stockholders are recorded. Delivery made to a corporation's registered office shall be by hand or by certified or registered mail, return receipt requested.

ARTICLE IV

Board of Directors

Section 4.01. Powers; Personal Liability.

(a) General Rule. - Unless otherwise provided by statute, all powers vested by law in the corporation shall be exercised by or under the authority of, and the business and affairs of the corporation shall be managed under the direction of, the board of directors.

(b) Personal Liability of Directors. -

A director of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (A) for any breach of the director's duty of loyalty to the corporation or its stockholders, (B) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (C) under Section 174 of the Delaware General Corporation Law or (D) for any transaction from which the director derives an improper personal benefit. If the Delaware General Corporation Law is amended after this Section
4.01 (b) becomes effective to authorize elimination or limitation of liability of directors, then, upon the effective date of any such amendment, the liability of a director of the corporation shall, without further act, be eliminated or limited to the fullest extent permitted by the Delaware General Corporation Law as so amended. Any repeal or modification of this section by the stockholders of the corporation shall not adversely affect any right or protection of a director of the corporation existing at the time of such repeal or modification.

Section 4.02. Qualifications and Selection of Directors.

(a) Qualifications. - Each director of the corporation shall be a natural person of full age who need not be a resident of the State of Delaware or a stockholder of the corporation.

-8-

(b) Election of Directors. - In elections for directors, voting need not be by ballot, unless required by vote of the stockholders before the voting for the election of directors begins. The candidates receiving the highest number of votes from each class or group of classes, if any, entitled to elect directors separately up to the number of directors to be elected by the class or group of classes shall be elected. If at any meeting of stockholders, directors of more than one class are to be elected, each class of directors shall be elected in a separate election.

Section 4.03. Number and Term of Office.

(a) Number. - The board of directors shall consist of such number of directors, not less than three (3) nor more than fifteen (15), as may be determined from time to time by resolution of the board of directors.

(b) Term of Office. - Each director shall hold office until the expiration of the term for which he or she was selected and until a successor has been selected and qualified or until his or her earlier death, resignation or removal. A decrease in the number of directors shall not have the effect of shortening the term of any incumbent director.

(c) Resignation. - Any director may resign at any time upon written notice to the corporation. The resignation shall be effective upon receipt thereof by the corporation or at such subsequent time as shall be specified in the notice of resignation.

(d) Classified Board of Directors - The directors shall be classified in respect of the time for which they shall severally hold office as follows:

(1) Each class shall be as nearly equal in number as possible.

(2) The term of office of at least one class shall expire in each year.

(3) With the exception of the classes of the initial board of directors, the members of each class shall be elected for a period of three years.

(4) The initial Board of Directors shall be classified into three (3) classes with (i) Class I serving until the annual meeting of stockholders next following January 31, 1998; (ii) Class II serving until the annual meeting of stockholders next following January 31, 1999; (ii) and Class III serving until the annual meeting of stockholders next following January 31, 1997; in each case such directors shall serve until a successor has been duly elected and qualified, or until his or her earlier death, resignation or removal.

Section 4.04. Vacancies.

(a) General Rule. - Vacancies in the board of directors, including vacancies resulting from an increase in the number of directors, may be filled by a majority vote of the remaining members of the board though less than a quorum, or by a sole remaining director, and each person so selected shall be a director to serve until the next selection of the class for which such director has been chosen, and until a successor has been selected and qualified or until his or her earlier death, resignation or removal.

-9-

(b) Action by Resigned Directors - When one or more directors resign from the board effective at a future date, the directors then in office, including those who have so resigned, shall have power by the applicable vote to fill the vacancies, the vote thereon to take effect when the resignations become effective.

Section 4.05. Removal of Directors. - The entire board of directors, or any class of the board, or any individual director may be removed from office by vote of the stockholders entitled to vote thereon without assigning any cause. In case the board or a class of the board or any one or more directors are so removed, new directors may be elected at the same meeting.

Section 4.06. Place of Meetings. - Meetings of the board of directors may be held at such place within or without the State of Delaware as the board of directors may from time to time appoint or as may be designated in the notice of the meeting.

Section 4.07. Organization of Meetings. - At every meeting of the board of directors, the Chairman of the Board, if there be one, or, in the case of a vacancy in the office or absence of the Chairman of the Board, one of the following offices present in the order stated: the Vice Chairman of the Board, if there be one, the President, the vice presidents in their order of rank and seniority, or a person chosen by a majority of the directors present, shall act as chairman of the meeting. The Secretary or, in the absence of the Secretary, an assistant secretary, or, in the absence of the Secretary and the assistant secretaries, any person appointed by the chairman of the meeting, shall act a secretary of the meeting.

Section 4.08. Regular Meetings. - Regular meetings of the board of directors shall be held at such time and place as shall be designated from time to time by resolution of the board of directors.

Section 4.09. Special Meetings - Special meetings of the board of directors shall be held whenever called by the Chairman or by two or more of the directors.

Section 4.10. Quorum of and Action by Directors.

(a) General Rule. A majority of the directors in office of the corporation shall be necessary to constitute a quorum for the transaction of business and the acts of a majority of the directors present and voting at a meeting at which a quorum is present shall be the acts of the board of directors.

(b) Action by Written Consent - Any action required or permitted to be taken at a meeting of the directors may be taken without a meeting if a consent or consents thereto signed by all the directors in office is filed with the Secretary of the corporation.

Section 4.11. Executive and Other Committees.

(a) Establishment and Powers - The board of directors may, by resolution adopted by a majority of the entire board, establish one or more committees consisting of one or more directors of the corporation. Any committee, to the extent provided in the resolution of the board of directors, shall have and may exercise all of the powers and authority of the board of directors except that a committee shall not have any power or authority as to the following:

(1) The amendment of the Certificate (except that a committee may, to the extent authorized in the resolution or resolutions providing for the issuance of shares of stock adopted by the

-10-

board of directors as provided in Section 151(a) of the Delaware General Corporation Law, fix the designations and any of the preferences or rights of such shares relating to dividends, redemption, dissolution, any distribution of assets of the corporation or the conversion into, or the exchange of such shares for, shares of any other class or classes or any other series of the same or any class or classes of stock for the corporation or fix the number of shares of any series of stock or authorize the increase or decrease of the shares of any series).

(2) The adoption of an agreement of merger or consolidation under Sections 251, 252, 254, 255, 256, 257, 258, 263 or 264 of the Delaware General Corporation Law.

(3) The recommendation to the stockholders of a sale, lease or exchange of all or substantially all of the corporation's property and assets.

(4) The recommendation to the stockholders of a dissolution of the corporation or revocation of a dissolution.

(5) The amendment of these bylaws.

(b) Alternate Committee Members - The board may designate one or more directors as alternate members of any committee who may replace any absent or disqualified member at any meeting of the committee or for the purposes of any written action by the committee. In the absence or disqualification of a member and alternate member or members of a committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not constituting a quorum, may unanimously appoint another director to act at the meeting in the place of the absent or disqualified member.

(c) Term. - Each committee of the board shall serve at the pleasure of the board.

(d) Committee Procedures. - The term "board of directors" or "board," when used in any provision of these bylaws relating to the organization or procedures of or the manner of taking action by the board of directors, shall be construed to include and refer to any executive or other committee of the board.

Section 4.12. Compensation. - The board of directors shall have the authority to fix the compensation of directors for their services as directors and a director may be a salaried officer of the corporation.

ARTICLE V

Officers

Section 5.01. Number, Qualifications and Designation. -The officers of the corporation shall be a President, one or more vice presidents, a Secretary, a Treasurer, and such other officers as may be elected in accordance with the provisions of Section 5.03. Officers may but need not be directors or stockholders of the corporation and shall be natural persons of full age. The board of directors may elect from among the members of the board a Chairman of the Board and a Vice Chairman of the Board who shall be officers of the corporation. Any number of offices may be held by the same person.

(b) Bonding. - The corporation may secure the fidelity of any or all of its officers by bond or otherwise.

-11-

(c) Standard of Care. - In lieu of the standards of conduct otherwise provided by law, officers of the corporation shall be subject to the same standards of conduct, including standards of care and loyalty and rights of justifiable reliance, as shall at the time be applicable to directors of the corporation.

Section 5.02. Election, Term of Office and Resignations.

(a) Election and Term of Office. - The officers of the corporation, except those elected by delegated authority pursuant to Section 5.03, shall be elected annually by the board of directors, and each such officer shall hold office for a term of one year and until a successor has been selected and qualified or until his or her earlier death, resignation or removal.

(b) Resignations. - Any officer may resign at any time upon written notice to the corporation. The resignation shall be effective upon receipt thereof by the corporation or at such subsequent time as may be specified in the notice of resignation.

Section 5.03. Subordinate Officers, Committees and Agents. - The board of directors may from time to time elect such other officers and appoint such committees, employees or other agents as the business of the corporation may require, including one or more assistant secretaries, and one or more assistant treasurers, each of whom shall hold office for such period, have such authority, and perform such duties as are provided in these bylaws, or as the board of directors may from time to time determine. The board of directors may delegate to any officer or committee the power to elect subordinate officers and to retain or appoint employees or other agents, or committees thereof, and to prescribe the authority and duties of such subordinate officers, committees, employees or other agents.

Section 5.04. Removal of Officers and Agents. - Any officer or agent of the corporation may be removed by the board of directors with or without cause. The removal shall be without prejudice to the contract rights, if any, of any person so removed. Election or appointment of an officer or agent shall not of itself create contract rights.

Section 5.05. Vacancies. - A vacancy in any office because of death, resignation, removal, disqualification, or any other cause, may be filled by the board of directors or by the officer or committee to which the power to fill such office has been delegated pursuant to Section 5.03, as the case may be, and if the office is one for which these bylaws prescribe a term, shall be filled for the unexpired portion of the term.

Section 5.06. Authority. - All officers of the corporation, as between themselves and the corporation, shall have such authority and perform such duties in the management of the corporation as may be provided by or pursuant to resolutions or orders of the board of directors or, in the absence of controlling provisions in the resolutions or orders of the board of directors, as may be determined by or pursuant to these bylaws.

Section 5.07. The Chairman and Vice Chairman of the Board. - The Chairman of the Board or in the absence of the Chairman, the Vice Chairman of the Board, shall preside at all meetings of the stockholders and of the board of directors, and shall perform such other duties as may from time to time be requested by the board of directors.

Section 5.08. The President. The President shall have general supervision over the business and operations of the corporation, subject however, to the control of the board of directors and, if the Chairman of the Board is the Chief Executive Officer of the corporation, the Chairman of the Board. The President shall sign, execute, and acknowledge, in the name of the corporation, deeds, mortgages, bonds,

-12-

contracts or other instruments, authorized by the board of directors, except in cases where the signing and execution thereof shall be expressly delegated by the board of directors, or by these bylaws, to some other officer or agent of the corporation; and, in general, shall perform all duties incident to the office of president and such other duties as from time to time may be assigned by the board of directors and, if the Chairman of the Board is the Chief Executive Officer of the corporation, the Chairman of the Board.

Section 5.09. The Vice Presidents. - The vice presidents shall perform the duties of the President in the absence of the President and such other duties as may from time to time be assigned to them by the board of directors or the President.

Section 5.10. The Secretary. - The Secretary or an assistant secretary shall attend all meetings of the stockholders and of the board of directors and all committees thereof and shall record all the votes of the stockholders and of the directors and the minutes of the meetings of the stockholders and of the board of directors and of committees of the board in a book or books to be kept for that purpose; shall see that notices are given and records and reports properly kept and filed by the corporation as required by law; shall be the custodian of the seal of the corporation and see that it is affixed to all documents to be executed on behalf of the corporation under its seal; and, in general, shall perform all duties incident to the office of secretary, and such other duties as may from time to time be assigned by the board of directors or the President.

Section 5.11. The Treasurer. - The Treasurer or an assistant treasurer shall or provide for the custody of the funds or other property of the corporation; shall collect and receive or provide for the collection and receipt of moneys earned by or in any manner due to or received by the corporation; shall deposit all funds in his or her custody as treasurer in such banks or other places of deposit as the board of directors may from time to time designate; shall, whenever so required by the board of directors, render an account showing all transactions as Treasurer, and the financial condition of the corporation; and, in general, shall discharge such other duties as may from time to time be assigned by the board of directors or the President.

Section 5.12. Salaries. - The salaries of the officers elected by the board of directors shall be fixed from time to time by the board of directors or by such officer as may be designated by resolution of the board. The salaries or other compensation of any other officers, employees and other agents shall be fixed from time to time by the President or by such other officer or committee to which the power to elect such officers or to retain or appoint such employees or other agents has been delegated pursuant to Section 5.03. No officer shall be prevented from receiving such salary or other compensation by reason of the fact that the officer is also a director of the corporation.

ARTICLE VI

Certificates of Stock, Transfer, Etc.

Section 6.01. Share Certificates.

(a) Form of Certificates. - Certificates for shares of the corporation shall be in such form as approved by the board of directors, and shall state that the corporation is incorporated under the laws of the State of Delaware, the name of the person to whom issued, and the number and class of shares and the designation of the series (if any) that the certificate represents. If the corporation is authorized to issue shares of more than one class or series, certificates for shares of the corporation shall set forth upon the face or back of the certificate (or shall state on the face or back of the certificate that the corporation will furnish to any stockholder upon request and without charge), a full or summary statement of the designations, voting rights,

-13-

preferences, limitations and special rights of the shares of each class or series authorized to be issued so far as they have been fixed and determined and the authority of the board of directors to fix and determine the designations, voting rights, preferences, limitations and special rights of the classes and series of shares of the corporation.

(b) Stock Ledger. - The stock ledger or transfer books and blank share certificates shall be kept by the Secretary or by any transfer agent or registrar designated by the board of directors for that purpose.

Section 6.02. Issuance. - The share certificates of the corporation shall be numbered and registered in the stock ledger or transfer books of the corporation as they are issued. They shall be executed in such manner as the board of directors shall determine. In case any officer, transfer agent or registrar who has signed or authenticated, or whose facsimile signature or authentication has been placed upon, and share certificate shall have ceased to be such officer, transfer agent or registrar because of death, resignation or otherwise, before the certificate is issued, the certificate may be issued with the same effect as if the officer, transfer agent or registrar had not ceased to be such at the date of its issue. The provisions of this Section 6.02 shall be subject to any inconsistent or contrary agreement in effect at the time between the corporation and any transfer agent or registrar.

Section 6.03. Transfer. - Transfers of shares shall be made on the share register or transfer books of the corporation upon surrender of the certificate therefor, endorsed by the person named in the certificate or by an attorney lawfully constituted in writing. No transfer shall be made inconsistent with the applicable provisions of the Uniform Commercial Code as in effect in the State of Delaware and its amendments and supplements.

Section 6.04. Record Holder of Shares. - The corporation shall be entitled to treat the person in whose name any share or shares of the corporation stand on the books of the corporation as the absolute owner thereof, and shall not be bound to recognize any equitable or other claim to, or interest in, such share or shares on the part of any other person.

Section 6.05. Lost, Destroyed or Mutilated Certificates. The holder of any shares of the corporation shall immediately notify the corporation of any loss, destruction or mutilation of the certificate therefor, and the board of directors may, in its discretion, cause a new certificate or certificates to be issued to such holder, in case of mutilation of the certificate, upon the surrender of the mutilated certificate or, in case of loss or destruction of the certificate, upon satisfactory proof of such loss or destruction and, if the board of directors shall so determine, the deposit of a bond in such form and in such sum, and with such surety or sureties, as it may direct.

ARTICLE VII

Indemnification of Directors, Officers and Other Authorized Representatives

Section 7.01. Scope of Indemnification.

(a) The corporation shall, to the fullest extent permitted by Section 145 of the Delaware General Corporation Law, as amended from time to time, indemnify every person who is or was a party, or is threatened to be made a party, to (i) any threatened, pending or completed action, suit or

-14-

proceeding, whether civil, criminal, administrative or investigative, or (ii) any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor, by reason of the fact that such person serves or has served at any time as a director or officer of the corporation, or who at the request of the corporation serves or at any time has served as a director or officer of another corporation (including subsidiaries of the corporation) or of any partnership, joint venture, trust or other enterprise, from and against any and all of the expenses, liabilities or other matters referred to in or covered by said law. Such indemnification shall continue as to a person who has ceased to be a director or officer and shall inure to the benefit of the heirs, executors and administrators of such a person. The corporation may also indemnify any and all other persons whom it shall have power to indemnify under any applicable law from time to time in effect to the extent authorized by the Board of Directors and permitted by such law. The indemnification provided by this Section 7.01 shall not be deemed exclusive of any other rights to which any person may be entitled under any provision of the Certificate, these bylaws, any agreement, vote of stockholders or disinterested directors, or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office.

(b) Partial Payment. - If an indemnified representative is entitled to indemnification in respect of a portion, but not all, of any liabilities to which such person may be subject, the corporation shall indemnify such indemnified representative to the maximum extent for such portion of the liabilities.

(c) Presumption. - The termination of a proceeding by judgment, order, settlement or conviction or upon a plea of nolo contendere or its equivalent shall not of itself create a presumption that the indemnified representative is not entitled to indemnification.

(d) Definitions. - Four purposes of this Article:

(1) "indemnified capacity" means any and all past, present and future service by an indemnified representative in one or more capacities as a director, officer, employee or agent of the corporation, or, at the request of the corporation, as a director, officer, employee, agent, fiduciary or trustee of another corporation, partnership, joint venture, trust, employee benefit plan or other entity or enterprise;

(2) "indemnified representative" means any and all directors and officers of the corporation and any other person designated as an indemnified representative by the board of directors of the corporation (which may, but need not, include any person serving at the request of the corporation, as a director, officer, employee, agent, fiduciary or trustee of another corporation, partnership, joint venture, trust, employee benefit plan or other entity or enterprise);

(3) "liability" means any damage, judgment, amount paid in settlement, fine, penalty, punitive damages, excise tax assessed with respect to an employee benefit plan, or cost or expense of any nature (including, without limitation, attorneys' fees and disbursements); and

(4) "proceeding" means any threatened, pending or completed action, suit, appeal or other proceeding of any nature, whether civil, criminal, administrative or investigative, whether formal or informal, and whether brought by or in the right of the corporation, a class of its security holders or otherwise.

Section 7.02. Proceedings Initiated by Indemnified Representatives. - Notwithstanding any other provision of this Article, the corporation shall not indemnify under this Article an indemnified representative for any liability incurred in a proceeding initiated (which shall not be deemed to include counter claims or affirmative defenses) or participated in as an intervenor or amicus curiae by the person

-15-

seeking indemnification unless such initiation of or participation in the proceeding is authorized, either before or after its commencement, by the affirmative vote of a majority of the directors in office. This section does not apply to reimbursement of expenses incurred in successfully prosecuting or defending an arbitration under Section 7.06 or otherwise successfully prosecuting or defending the rights of an indemnified representative granted by or pursuant to this Article.

Section 7.03. Advancing Expenses. - The corporation shall pay the expenses (including attorneys' fees and disbursements) incurred in good faith by an indemnified representative in advance of the final disposition of a proceeding described in Section 7.01 or the initiation of or participation in which is authorized pursuant to Section 7.02 upon receipt of an undertaking by or on behalf of the indemnified representative to repay the amount if it is ultimately determined pursuant to Section 7.06 that such person is not entitled to be indemnified by the corporation pursuant to this Article. The financial ability of an indemnified representative to repay an advance shall not be a prerequisite to the making of such advance.

Section 7.04. Securing of Indemnification Obligations. -To further effect, satisfy or secure the indemnification obligations provided herein or otherwise, the corporation may maintain insurance, obtain a letter of credit, act as self-insurer, create a reserve, trust, escrow, cash collateral or other fund or account, enter into indemnification agreements, pledge or grant a security interest in any assets or properties of the corporation, or use any other mechanism or arrangement whatsoever in such amounts, at such costs, and upon such other terms and conditions as the board of directors shall deem appropriate. Absent fraud, the determination of the board of directors with respect to such amounts, costs, terms and conditions shall be conclusive against all security holders, officers and directors and shall not be subject to voidability.

Section 7.05. Payment of Indemnification. - An indemnified representative shall be entitled to indemnification within 30 days after a written request for indemnification has been delivered to the Secretary of the corporation.

Section 7.06. Arbitration.

(a) General Rule. - Any dispute related to the right to indemnification, contribution or advancement of expenses as provided under this Article, except with respect to indemnification for liabilities arising under the Securities Act of 1933 that the corporation has undertaken to submit to a court for adjudication, shall be decided only by arbitration in the metropolitan area in which the principal executive offices of the corporation are located at the time, in accordance with the commercial arbitration rules then in effect of the American Arbitration Association, before a panel of three arbitrators, one of whom shall be selected by the corporation, the second of whom shall be selected by the indemnified representative and the third of whom shall be selected by the other two arbitrators. In the absence of the American Arbitration Association, or if for any reason arbitration under the arbitration rules of the American Arbitration Association cannot be initiated, and if one of the parties fails or refuses to select an arbitrator or the arbitrators selected by the corporation and the indemnified representative cannot agree on the selection of the third arbitrator within 30 days after such time as the corporation and the indemnified representative have each been notified of the selection of the other's arbitrator, the necessary arbitrator or arbitrators shall be selected by the presiding judge of the court of general jurisdiction in such metropolitan area.

(b) Qualifications of Arbitrators. - Each arbitrator selected as provided herein is required to be or have been a director or executive officer of a corporation whose shares of common stock were listed during at least one year of such service on the New York Stock Exchange or the American Stock Exchange or quoted on the National Association of Securities Dealers Automated Quotations System.

-16-

(c) Burden of Proof. - The party or parties challenging the right of an indemnified representative to the benefits of this Article shall have the burden of proof.

(d) Expenses. - The corporation shall reimburse an indemnified representative for the expenses (including attorneys' fees and disbursements) incurred in successfully prosecuting or defending such arbitration.

(e) Effect. - Any award entered by the arbitrators shall be final, binding and nonappealable and judgment may be entered thereon by any party in accordance with applicable law in any court of competent jurisdiction, except that the corporation shall be entitled to interpose as a defense in any such judicial enforcement proceeding any prior final judicial determination adverse to the indemnified representative under Section 7.01(a)(2) in a proceeding not directly involving indemnification under this Article. This arbitration provision shall be specifically enforceable.

Section 7.07. Contribution. - If the indemnification provided for in this Article or otherwise is unavailable for any reason in respect of any liability or portion thereof, the corporation shall contribute to the liabilities to which the indemnified representative may be subject in such proportion as is appropriate to reflect the intent of this Article or otherwise.

Section 7.08. Mandatory Indemnification of Directors, Officers, etc. - To the extent that an authorized representative of the corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in Section 145(a) or (b) of the Delaware General Corporation Law or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including attorneys' fees and disbursements) actually and reasonably incurred by such person in connection therewith.

Section 7.09. Contract Rights; Amendment or Repeal. -All rights under this Article shall be deemed a contract between the corporation and the indemnified representative pursuant to which the corporation and each indemnified representative intend to be legally bound. Any repeal, amendment or modification hereof shall be prospective only and shall not affect any rights or obligations then existing.

Section 7.10. Scope of Article. - The rights granted by this Article shall not be deemed exclusive of any other rights to which those seeking indemnification, contribution or advancement of expenses may be entitled under any statute, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in an indemnified capacity and as to action in any other capacity. The indemnification, contribution and advancement of expenses provided by or granted pursuant to this Article shall continue as to a person who has ceased to be an indemnified representative in respect of matters arising prior to such time, and shall inure to the benefit of the heirs, executors, administrators and personal representatives of such a person.

Section 7.11. Reliance on Provisions. - Each person who shall act as an indemnified representative of the corporation shall be deemed to be doing so in reliance upon the rights of indemnification, contribution and advancement of expenses provided by this Article.

ARTICLE VIII

Miscellaneous

Section 8.01. Corporate Seal. - The corporation shall have a corporate seal in the form of a circle containing the name of the corporation, the year of incorporation and such other details as may be

-17-

approved by the board of directors. The affixation of the corporate seal shall not be necessary to the valid execution, assignment or endorsement by the corporation of any instrument or other document.

Section 8.02. Checks. - All checks, notes, bills of exchange or other similar orders in writing shall be signed by such one or more officers or employees of the corporation as the board of directors may from time to time designate.

Section 8.03. Contracts.

(a) General Rule. - Except as otherwise provided in the Delaware General Corporation Law in the case of transactions that require action by the stockholders, the board of directors may authorize any officer or agent to enter into any contract or to execute or deliver any instrument on behalf of the corporation, and such authority may be general or confined to specific instances.

(b) Statutory Form of Execution of Instruments. - Any note, mortgage, evidence of indebtedness, contract or other document, or any assignment or endorsement thereof, executed or entered into between the corporation and any other person, when signed by one or more officers or agents having actual or apparent authority to sign it, or by the President or Vice President and Secretary or Assistant Secretary or Treasurer or Assistant Treasurer of the corporation, shall be held to have been properly executed for and in behalf of the corporation, without prejudice to the rights of the corporation against any person who shall have executed the instrument in excess of his or her actual authority.

Section 8.04. Interested Directors or Officers; Quorum.

(a) General Rule. - A contract or transaction between the corporation and one or more of its directors or officers or between the corporation and another corporation, partnership, joint venture, trust or other enterprise in which one or more of its directors or officers are directors or officers or have a financial or other interest, shall not be void or voidable solely for that reason, or solely because the director or officer is present at or participates in the meeting of the board of directors that authorizes the contract or transaction, or solely because his, her or their votes are counted for that purpose, if:

(1) the material facts as to the relationship or interest and as to the contract or transaction are disclosed or are known to the board of directors and the board authorizes the contract or transaction by the affirmative votes of a majority of the disinterested directors even though the disinterested directors are less than a quorum; or

(2) the material facts as to his or her relationship or interest and as to the contract or transaction are disclosed or are known to the stockholders entitled to vote thereon and the contract or transaction is specifically approved in good faith by vote of those stockholders; or

(3) the contract or transaction is fair as to the corporation as of the time it is authorized, approved or ratified by the board of directors or the stockholders.

(b) Quorum. - Common or interested directors may be counted in determining the presence of a quorum at a meeting of the board which authorizes a contract or transaction specified in subsection (a).

Section 8.05. Deposits. - All funds of the corporation shall be deposited from time to time to the credit of the corporation in such banks, trust companies or other depositaries as the board of directors

-18-

may approve or designate, and all such funds shall be withdrawn only upon checks signed by such one or more officers or employees of the corporation as the board of directors shall from time to time designate.

Section 8.06. Corporate Records.

(a) Required Records.- The corporation shall keep complete and accurate books and records of account, minutes of the proceedings of the incorporators, stockholders and directors and a stock ledger giving the names and addresses of all stockholders and the number and class of shares held by each. The stock ledger shall be kept at either the registered office of the corporation in the State of Delaware or at its principal place of business wherever situated or at the office of its registrar or transfer agent. Any books, minutes or other records may be in written form or any other form capable of being converted into written form within a reasonable time.

(b) Right of Inspection. - Every stockholder shall, upon written demand under oath stating the purpose thereof, have a right to examine, in person or by agent or attorney, during the usual hours for business for any proper purpose, the stock ledger, list of stockholders and other books and records, and to make copies or extracts therefrom. A proper purpose shall mean a purpose reasonably related to the interest of the person as a stockholder. In every instance where an attorney or other agent is the person who seeks the right of inspection, the demand under oath shall be accompanied by a verified power of attorney or other writing that authorizes the attorney or other agent to so act on behalf of the stockholder. The demand under oath shall be directed to the corporation at its registered office in the State of Delaware or at its principal place of business wherever situated.

Section 8.07. Amendment of Bylaws. - These bylaws may be amended or repealed, or new bylaws may be adopted, either (i) by vote of the stockholders at any duly organized annual or special meeting of stockholders, or (ii) by vote of a majority of the board of directors of the corporation in office at any regular or special meeting of directors. Any change in these bylaws shall take effect when adopted unless otherwise provided in the resolution effecting the change.

* * * * *

-19-

Exhibit 10.(i)

EMPLOYMENT AGREEMENT

This Agreement is entered into this 3 day of May, 2001 by and between ICHOR CORPORATION, a Delaware corporation (hereinafter referred to as the "COMPANY"), and Pierre-Francois Serres, an individual residing in France, 52 Avenue Chanoine Cartellier, F-69230 Saint-Genis-Laval (hereinafter referred to as "EXECUTIVE") under the following terms and conditions:

RECITALS:

WHEREAS, the Company and Executive desire to set forth the terms and conditions on which (i) the Company shall employ Executive, (ii) Executive shall render services to the Company, and (iii) the Company shall compensate Executive for such services; and

WHEREAS, in connection with the employment of Executive by the Company, the Company desires to restrict Executive's rights to compete with the business of the Company;

NOW, THEREFORE, in consideration of the mutual promises, covenants and agreements hereinafter set forth, the parties hereto agree as follows:

1. EMPLOYMENT.

The Company hereby employs Executive and Executive hereby accepts employment with the Company upon the terms and conditions hereinafter set forth. This contract shall be governed by the terms and the conditions of the National Collective Bargaining Agreement for the Pharmaceutical Industry (Convention Collective National de l'Industry Pharmaceutique).

2. PLACE OF WORK

2.1 Executive is hired to work at the registered offices of the Company, and in all the sites where the Company is and may become active. Executive, however, recognizes that he may be required, for the performance of his employment contract, to travel abroad or in France, and Executive agrees to travel, irrespective of duration.

3. TERM.

3.1 This Contract is entered into for an indefinite term, subject, however, to termination as provided herein in Sections 7 and 8 below.

3.2 Each year, prior to the anniversary date, the Company and Executive shall meet to determine additional compensation, if any.

3.3 The effective date of this Agreement shall be April 1, 2001 (the "EFFECTIVE DATE").


4. COMPENSATION.

4.1 For all services rendered by Executive under this Agreement, the Company shall pay or cause one or more of its subsidiaries to pay Executive during the Executive's employment, a gross salary at the rate of fifty thousand French Francs (50,000 FRF) per month from which the Company will withhold all statutory withholdings. Such compensation shall be paid monthly to Executive by Hippocampe, a wholly owned subsidiary of the Company, in accordance with its standard practice for payment of compensation to its employees.

4.2 Executive shall be entitled to periodic cash bonuses in addition to stock bonuses in accordance with the Company's stock option plans now in effect or hereafter adopted, any other incentive bonus plans or other forms of compensation, at the discretion of the Company's Board of Directors, dependent upon Employee's performance.

4.3 Executive shall be entitled to normal benefits for all Company employees and be entitled to participate in the Company's stock option plan.

4.4 The compensation granted to Executive has been set according to his functions and shall be considered as a lump sum compensation, which includes Executive's overtime.

5. DUTIES AND RESPONSIBILITIES.

5.1 Executive shall, during the Term of this Agreement unless otherwise agreed by management, devote his full attention and expend his best efforts, energies, and skills on a full-time basis, to the business of the Company and any corporation controlled by the Company (each, a "SUBSIDIARY"). The Company acknowledges that Executive may from time to time be engaged in other business activities separate from and outside the scope of the business of the Company. The Company agrees that the devotion of reasonable amounts of time to such other business activities will not violate the terms of this Agreement on the conditions that (i) such activities are not corporate opportunities of the Company; and (ii) such activities do not interfere with the performance of Executive's duties hereunder. For purposes of this Agreement, the term the "COMPANY" shall mean the Company and all Subsidiaries.

5.2 During the Term of this Agreement, Executive shall serve as the President and Chief Executive Officer of the Company or in such other capacities as determined by the Board of Directors except as provided for under Subsection 7.1. In the performance of all of his responsibilities hereunder, Executive shall be subject to all of the Company's policies, rules, and regulations applicable to its executive of comparable status and shall report directly to, and shall be subject to, the direction and control of the Board of Directors of the Company and shall perform such duties as shall be assigned to him by the Board of Directors. In performing such duties, Executive will be subject to and abide by, and will use his best efforts to cause other employees of the Company to be subject to and abide by, all policies and procedures developed by the Executive Committee or senior management of the Company. Executive recognizes that his duties shall evolve if the expansion and/or the organization of the Company so requires.

-2-

5.3 To induce the Company to enter into this Agreement, Executive represents and warrants to the Company that (i) except for the existing contracts with SCERICIA and GLES which do not conflict with Executive's obligations under this Agreement (as described on Exhibit A) Executive is not a party or subject to any employment agreement or arrangement with other person, firm, company, corporation or other business entity, (ii) Executive is subject to no restraint, limitation or restriction by virtue of any law or rule of law or otherwise which would impair Executive's right or ability (a) to enter the employ of the Company, or (b) to perform fully his duties and obligations pursuant to this Agreement.

6. RESTRICTIVE COVENANTS.

6.1 Executive acknowledges that (i) he has a major responsibility for the operation, administration, development and growth of the Company's business, (ii) the Company's business has become international in scope, (iii) his work for the Company has brought him and will continue to bring him into close contact with confidential information of the Company and its customers, and (iv) the agreements and covenants contained in this Subsection 6.1 are essential to protect the business interests of the Company and that the Company will not enter into this Agreement but for such agreements and covenants. Accordingly, Executive covenants and agrees as follows:

6.1.1 Except as otherwise provided for in this Agreement, during the Term of this Agreement Executive shall not, directly or indirectly, compete with respect to any services or products of the Company which are either offered or are being developed by the Company as of the date of termination; or, without limiting the generality of the foregoing, by or become, or agree to be or become, interested in or associated with, in any capacity (whether as a partner, shareholder, owner, officer, director, Executive, principal, agent, creditor, trustee, consultant, co-venturer or otherwise) any individual, corporation, firm, association, partnership, joint venture or other business entity, which competes with respect to any services or products of the Company which are either offered or are being developed by the Company as of the date of termination; provided, however, that Executive may own, solely as an investment, not more than one percent (1%) of any class of securities of any publicly held corporation in competition with the Company whose securities are traded on any securities exchange.

6.1.2 During the Term of this Agreement and, for two years thereafter ("TERMINATION PERIOD"), Executive shall not, directly or indirectly, (i) induce or attempt to influence any employee of the Company to leave its employ, (ii) aid or agree to aid any competitor, customer or supplier of the Company in any attempt to hire any person who shall have been employed by the Company within the one (1) year period preceding such requested aid, or
(iii) induce or attempt to influence any person or business entity who was a customer or supplier of the Company during any portion of said period to transact business with a competitor of the Company in Company's business.

6.1.3 During the Term of this Agreement, the Termination Period and any time thereafter, Executive shall not disclose to anyone any information about the confidential or proprietary affairs of the Company, including, without limitation, trade secrets, trade "know-how",

-3-

inventions, customer lists, business plans, operational methods, pricing policies, marketing plans, sales plans, identity of suppliers or customers, sales, profits or other financial information, which is confidential to the Company or is not generally known in the relevant trade, nor shall Executive make use of any such information for his own benefit.

6.1.4. These non-competition provisions shall be enforceable during a period of two years following the termination of Executive's employment contract, and, in light of the world wide scope of the agreement, will be enforceable in all countries.

6.1.5. In consideration for his compliance with the non-competition provisions, the Executive shall receive a non-compete compensation during the aforementioned Termination Period. If the Agreement is terminated by the Company, this monthly compensation will amount to 33% of the average monthly gross salary which had been paid to the Executive during the first 2 years of the Agreement. If the Agreement is terminated by the Executive, this monthly compensation will amount to 33% of the average monthly gross salary which had been paid to the Executive during the last twelve (12) months of the Agreement. In case of breach of the non compete provisions by Executive, the non competition compensation shall no longer be payable to the Executive and the Executive shall reimburse the Company for all the non competition compensation which the Company already has paid to the Executive.

6.2 If Executive breaches Subsection 6.1 (the "RESTRICTIVE COVENANTS"), the Company shall have the following rights and remedies, which shall be enforceable, and is in addition to, and not in lieu of, any other rights and remedies available to the Company at law or in equity.

6.2.1 Executive acknowledges and agrees that in the event of a violation or threatened violation of any of the provisions of Subsection 5.1.1, the Company shall have no adequate remedy at law and shall therefore be entitled to enforce each such provision by temporary or permanent injunctive or mandatory relief obtained in any court of competent jurisdiction without the necessity of proving damages, posting any bond or other security, and without prejudice to any other rights and remedies which may be available at law or in equity.

6.3 If any of the Restrictive Covenants, or any part thereof, is held to be invalid or unenforceable, the same shall not affect the remainder of the covenant or covenants, which shall be given full effect, without regard to the invalid or unenforceable portions. Without limiting the generality of the foregoing, if any of the Restrictive Covenants, or any part thereof, is held to be unenforceable because of the duration of such provision or the area covered thereby, the parties hereto agree that the court making such determination shall have the power to reduce the duration and/or area of such provision and, in its reduced form, such provision shall then be enforceable.

6.4 The parties hereto intend to and hereby confer jurisdiction to enforce the Restrictive Covenants upon the courts of any jurisdiction within the geographical scope of such Restrictive Covenants. In the event that the courts of any one or more of such jurisdictions shall hold such Restrictive Covenants wholly unenforceable by reason of the breadth of such scope or otherwise, it is the intention of the parties hereto that such determination not bar or in any way

-4-

affect the Company's right of the relief provided above in the courts of any other jurisdictions within the geographical scope of such Restrictive Covenants, as to breaches of such covenants in such other respective jurisdictions, the above covenants as they relate to each jurisdiction being, for this purpose, severable into diverse and independent covenants.

7. TERMINATION.

7.1 The Company and Executive may each terminate this employment at any time, with a 3 months notice period, except in case for dismissal for Cause. Upon election to terminate the Agreement, the Company may exercise two options:

(i) it may ask Executive to leave the day-to-day employ of the Company and remain as a consultant; or

(ii) sever all relationships with the Company whatsoever.

In either case, the Executive shall be entitled to compensation, as defined in Sections 4 (base salary) of twenty-four (24) months gross salary; this amount shall include any other compensation and allowance granted by the aforesaid Collective Bargaining Agreement and by the provisions of law applicable in this case.

7.2 The Company also may terminate Executive's employment under this Agreement at any time for Cause. "CAUSE" shall exist for such termination if Executive (i) is adjudicated guilty of illegal activities involving moral turpitude by a court of competent jurisdiction, (ii) commits any act of fraud or intentional misrepresentation intended to harm the Company,
(iii) has engaged in serious misconduct, which conduct has, or would, if generally known, materially adversely affect the good will or reputation of the Company and which conduct Executive has not cured or altered within ten (10) days following written notice by the Board to Executive regarding such conduct,
(iv) is in material breach under this Agreement, or (v) Executive habitually fails to perform the duties and responsibilities of his employment as set forth in Section 4 of this Agreement or as may be assigned or delegated to him from time to time by the Company, or the Board, and, with regard to grounds (iv) and
(v) the Board has given Executive thirty (30) days written notice of the grounds for the termination and the conduct required by Executive to cure such failure, with such conduct outlined with reasonable specificity, and Executive has not cured such failure, within the thirty (30) day period provided in the written notice to Executive.

7.3 If the Company terminates Executive's employment under this Agreement pursuant to the provisions of Subsections 7.2, Executive shall not be entitled to receive any severance pay.

7.4 If Executive's employment with the Company is terminated due to the death, the spouse of the Executive, the estate of Executive or the Executive, as the case may be, shall continue to receive compensation as determined in Section 8 below.

-5-

7.5 If Executive's employment with the Company is terminated as the result of Executive's purely voluntary resignation for reasons other than those set forth in Section 7 below, Executive shall not be entitled to compensation after the effective date of such resignation other than as provided for in Section 6.1.5. For purposes of this subsection 7.5, a voluntary termination does not include termination initiated by the Executive in such circumstances as an unfavorable change in his duties and responsibilities or reporting responsibilities, or a reduction in base salary proposed by the Board. A termination of the nature described in the preceding sentence shall be considered a termination by the Board of Directors of the Company without "Cause" for purposes of this Agreement.

8. TERMINATION COMPENSATION.

8.1 Compensation as defined in Sections 4.1 (base salary) above shall continue for a period of twenty-four (24) months following the date of termination in the event: (i) the Company terminates the Agreement pursuant to Section 7.1; (ii) the death of Executive, said amount being paid to his spouse or estate as the case may be; (iii) the Executive resigns due to a substantial change in ownership or Board membership as defined below.

8.2 A substantial change in ownership shall mean: (i) the sale of over 50% of the corporation's assets, or (ii) a change in ownership of over 30% of the outstanding stock of the Company; or (iii) the replacement or change of over 65% of the Board in one fiscal year.

8.3 In the event Executive is requested to resign, employment is terminated for any reason by the Company, including termination under Sections 6 or 7 or in the event Executive voluntarily resigns as a result of any of the events set forth in Section 7.1 above, then, and in any of such events, all of the Executive's rights under the Company's Stock Option Plan and all other incentive bonus plans shall fully and completely vest upon the date of such termination and any early termination provisions provided for in such plans shall not apply to rights or options granted to Executive.

9. EXPENSES.

9.1 Executive shall be entitled to reimbursement of all reasonable expenses actually incurred in the course of his employment. Executive shall submit to the Company a standardized expense report form, provided by the Company, and shall attach thereto receipts for all expenditures. Expenses shall include business travel, automobile expenses, and temporary lodging.

9.2 The Company shall reimburse Executive within fifteen (15) days after submission by Executive of his expense report.

10. THE COMPANY'S AUTHORITY.

Executive agrees to observe and comply with the reasonable rules and regulations of the Company as adopted by the Company's Board of Directors, either orally or in writing,

-6-

respecting performances of his duties and to carry out and perform orders, directions, and policies stated by the Board of Directors, to him from time to time, either orally or in writing.

11. PAID VACATION; SICK LEAVE; INSURANCE.

11.1 Executive shall be entitled to a paid vacation each year equal to all paid holidays in accordance and set forth in the law and in the applicable Collective Bargaining Agreement, but this paid vacation shall not be less than six (6) weeks per year in addition to the statutory paid holidays on which the Company's offices are closed.

11.2 Executive shall be entitled to reasonable periods of paid sick leave during the Term of the Agreement in accordance with the Company's policy regarding such sick leave.

12. LEGAL DEFENSE; AND INDEMNIFICATION.

The Company acknowledges that the Biotech industry is a litigious industry whereby many regulatory fines, penalties and third-party suits are directed at the individuals involved in ownership and operations. The Company agrees to pay all legal fees, judgments, awards, bonds, fines, penalties and costs related to the defense and outcome whereby Executive was acting in his corporate capacity. The Company acknowledges that from time to time the Executive becomes contingently liable for obligations of the Company. The Company will make whole the Executive in case such contingent obligations becomes direct. Also, in the event that Executive leaves the employ of the Company for any reason, the Company will use its best efforts to remove the Executive from such liabilities, whether contingent or direct.

13. MISCELLANEOUS.

13.1 The Company may, from time to time, apply for and take out, in its own name and at its own expense, life, health, accident, disability or other insurance upon Executive in any sum or sums that it may deem necessary to protect its interests, and Executive agrees to aid and cooperate in all reasonable respects with the Company in procuring any and all such insurance, including without limitation, submitting to the usual and customary medical examinations, and by filling out, executing and delivering such applications and other instruments in writing as may be reasonably required by an insurance company or companies to which an application or applications for such insurance may be made by or for the Company.

13.2 This Agreement is a personal contract, and the rights and interests of Executive hereunder may not be sold, transferred, assigned, pledged or hypothecated except as otherwise expressly permitted by the provisions of this Agreement. Executive shall not under any circumstances have any option or right to require payment hereunder otherwise than in accordance with the terms hereof. Except as otherwise expressly provided herein, Executive shall not have any power of anticipation, alienation or assignment of payments contemplated hereunder, and all rights and benefits of Executive shall be for the sole personal benefit of Executive, and no other person shall acquire any right, title or interest hereunder by reason of any sale, assignment, transfer, claim or judgment or bankruptcy proceedings against Executive; provided, however, that in the event of Executive's death, Executive's estate, legal representative

-7-

or beneficiaries (as the case may be) shall have the right to receive all of the benefit that accrued to Executive pursuant to, and in accordance with, the terms of this Agreement.

13.3 The Company shall have the right to assign this Agreement to any successor of substantially all of its business or assets, and any such successor and Executive shall be bound by all of the provisions hereof.

14. NOTICES.

All notices, requests, demands and other communications provided for by this Agreement shall be in writing and (unless otherwise specifically provided herein) shall be deemed to have been given three (3) days after having been mailed in any general or branch United States Post office, enclosed in a registered or certified postpaid envelope, addressed to the parties stated below or to such changed address as such party may have fixed by notice:

TO THE COMPANY:      ICHOR CORPORATION
                     17 Dame Street
                     Dublin 2, Ireland

COPY TO:             James D. Chiafullo, Esq.
                     Cohen & Grigsby, P.C.
                     11 Stanwix Street, 15th Floor
                     Pittsburgh, PA 15222


EXECUTIVE:           50-52 Avenue Chanoine Cartellier
                     69230 Saint-Genis-Laval
                     France

15. ENTIRE AGREEMENT.

This Agreement supersedes any and all Agreements, whether oral or written, between the parties hereto, with respect to the employment of Executive by the Company and contains all of the covenants and Agreements between the parties with respect to the rendering of such services in any manner whatsoever. Each party to this Agreement acknowledges that no representations, inducements, promises or agreements, orally or otherwise, have been made by any party, or anyone acting on behalf of any party, which are not embodied herein, and that no other agreement, statement or promise with respect to such employment not contained in this Agreement shall be valid or binding. Any modification of this Agreement will be effective only if it is writing and signed by the parties hereto.

-8-

16. PARTIAL INVALIDITY.

If any provision in this Agreement is held by a court of competent jurisdiction to be invalid, void, or unenforceable, the remaining provisions shall nevertheless continue in full force and effect without being impaired or invalidated in any way.

17. ATTORNEYS FEES.

Except with respect to paragraphs 6.3 and 6.4 which issues are reserved for the court, any dispute regarding the negotiations leading up to the execution of this Release and/or the interpretation or application of this Agreement or the alleged breach hereof, or any act which allegedly has, or would, violate any provision of this Agreement must be submitted to arbitration before a neutral arbitrator. The arbitration shall be conducted in accordance with the rules of American Arbitration Association. A written demand for arbitration pursuant to Section 638 of the Code of Civil Procedure must be made within sixty (60) days of the alleged breach. The results of arbitration will be the exclusive, final and binding remedy for such claim or dispute.

18. GOVERNING LAW.

This Agreement will be governed by and construed in accordance with the laws of the State of Delaware.

19. BINDING NATURE.

This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective representatives, heirs, successors and assigns.

20. WAIVER.

No waiver of any of the provisions of this Agreement shall be deemed, or shall constitute a waiver of any other provision, whether or not similar, nor shall any waiver constitute a continuing waiver. No waiver shall be binding unless executed in writing by the party making the waiver.

21. CORPORATE APPROVALS.

The Company represents and warrants that the execution of this Agreement by its corporate officer named below has been duly authorized by the Board of Directors of the Company, is not in conflict with any Bylaw or other agreement and will be a binding obligation of the Company, enforceable in accordance with its terms.

[REST OF THE PAGE INTENTIONALLY LEFT BLANK]

-9-

IN WITNESS WHEREOF, the parties hereto have executed this Agreement in two original copies as of the date above written.

THE COMPANY:

By: /s/ M. Eric Turcotte
    ---------------------------------------
    Member of Board of Directors

EXECUTIVE:

/s/ Pierre-Francois Serres
-------------------------------------------
Pierre-Francois Serres

-10-

EXHIBIT A

1. Description of Agreement with SCERICIA

Executive acted as general manager for SCERICIA. Executive represents that SCERICIA is an inactive company.

2. Description of Agreement with GLES

Group Lyonnais of Specific Epuration is an active company (Therapeutic Cartridges) which is pursuing complementary research in the biotechnology field with Hippocampe. Executive acts as Vice President of GLES and represents that there are no conflicts with this engagement and his engagements under the Agreement.

NB: The patents of Pr. J TRAEGER President of GLES were bought by HIPPOCAMPE.

-11-

Exhibit 10.(ii)

SERVICES AGREEMENT

This Agreement is entered into this 31st day of May, 2001 by and between ICHOR CORPORATION, a Delaware corporation (the "COMPANY"), and MFC MERCHANT BANK, S.A. (the "BANK") under the following terms and conditions.

RECITALS

The Company and the Bank desire to set forth the terms and conditions on which (i) the Bank shall make available to the Company, the services of John M. Musacchio ("EXECUTIVE"), (ii) Executive shall render services to the Company, and (iii) the Company shall compensate the Bank for such services; and therefore, in consideration of the mutual promises, covenants and agreements hereinafter set forth, the parties hereto agree as follows:

1. SERVICES.

The Bank hereby makes available, and the Company hereby accepts, the services of Executive to be performed for the Company upon the terms and conditions hereinafter set forth.

2. TERM.

2.1 The term of this Agreement (the "TERM") shall be for a one-year period commencing on the Effective Date (as defined in Subsection 2.2 below) of this Agreement, subject, however, to termination as provided herein in Sections 6 and 7 below.

2.2 The effective date of this Agreement shall be May 30, 2001 (the "EFFECTIVE DATE").

3. COMPENSATION.

For all services rendered by Executive under this Agreement, the Company shall pay or cause one or more of its subsidiaries to pay the Bank as reimbursement for Executive's efforts during the term hereof a fee at the rate of Five Thousand Euros (<128> 5,000) per month.

4. DUTIES AND RESPONSIBILITIES.

4.1 Executive shall, during the Term of this Agreement unless otherwise agreed by management, devote his attention and expend his best efforts, energies, and skills as may be required, to the business of the Company and any corporation controlled by the Company (each, a "SUBSIDIARY"). The Company


acknowledges that Executive is engaged in other business activities separate from and outside the scope of the business of the Company. The Company agrees that the devotion of time to such other business activities will not violate the terms of this Agreement. For purposes of this Agreement, the term the "Company" shall mean the Company and all Subsidiaries.

4.2 During the Term of this Agreement, Executive shall serve as the Chief Operating Officer of the Company or in such other capacities as determined by the Board of Directors (the "BOARD"). Executive's responsibilities are set forth on Exhibit A, which is an integral part of this Agreement. In the performance of all of his responsibilities hereunder, Executive shall be subject to all of the Company's policies, rules, and regulations applicable to its executives of comparable status and shall report directly to, and shall be subject to, the direction and control of the CEO and shall perform such duties as shall be assigned to him by the CEO. In performing such duties, Executive will be subject to and abide by, and will use his best efforts to cause the employees of the Company to be subject to and abide by, all policies and procedures developed by the senior management of the Company.

4.3 To induce the Company to enter into this Agreement, the Bank and Executive represent and warrant to the Company that neither the Bank nor the Executive are subject to any restraint, limitation or restriction by virtue of any law or rule of law or otherwise which would impair Executive's right or ability (i) to render services to the Company, or (ii) to perform fully his duties and obligations pursuant to this Agreement.

5. RESTRICTIVE COVENANT.

5.1 The bank and Executive acknowledge that Executive's engagement for the Company has brought the Executive and will continue to bring the Executive into close contact with confidential information of the Company, and that the agreement and covenant contained in this Subsection 5.1 are essential to protect the business interests of the Company and that the Company will not enter into this Agreement but for such agreement and covenant. Accordingly, both the Bank and the Executive covenant and agree that during the Term of this Agreement, and any time thereafter, neither the Bank nor the Executive shall disclose to anyone any information about the confidential or proprietary affairs of the Company, including, without limitation, trade secrets, trade "know-how", inventions, customer lists, business plans, operational methods, pricing policies, marketing plans, sales plans, identity of suppliers or customers, sales, profits or other financial information, which is confidential to the Company or is not generally known in the relevant trade, nor shall the bank or the Executive make use of any such information for their own benefit or otherwise.

5.2 If Executive breaches Subsection 5.1, the Company shall have all rights and remedies available to the Company at law or in equity.

-2-

6. TERMINATION.

6.1 The basic one-year term shall automatically be renewed each year on the anniversary date of this Agreement, unless the Company elects to terminate the Agreement. Upon election to terminate the Agreement, the Company may exercise two options.

(i) It may ask the Bank whether Executive may remain as a consultant; or

(ii) it may sever all Executive's relationships with the Company.

In either case, the Bank shall be entitled to compensation, as defined in Section 3 during the remainder of the one-year term.

6.2 During the term of this Agreement, the Company may only terminate Executive's engagement under this Agreement for Cause. "Cause" shall exist if Executive (i) is adjudicated guilty of illegal activities involving moral turpitude by a court of competent jurisdiction, (ii) commits any act of fraud or intentional misrepresentation intended to harm the Company, (iii) has engaged in serious misconduct, which conduct has, or would, if generally known, materially adversely affect the good will or reputation of the Company and which conduct Executive has not cured or altered within ten (10) days following written notice by the Board to Executive regarding such conduct, (iv) is in material breach under this Agreement, or (v) Executive habitually fails to perform the duties and responsibilities as set forth in Section 4 of this Agreement or as may be assigned or delegated to him from time to time by the Company or the Board, and, with regard to grounds (iv) and (v) the Board has given Executive thirty (30) days written notice of the grounds for the termination and the conduct required by Executive to cure such failure, with such conduct outlined with reasonable specificity, and Executive has not cured such failure, within the thirty (30) day period provided in the written notice to Executive.

7. EXPENSES.

7.1 The Bank shall be entitled to reimbursement of all reasonable expenses actually incurred in the course of this Agreement. The Bank or Executive shall submit to the Company a standardized expense report form, provided by the Company, and shall attach thereto receipts for all expenditures.

7.2 The Company shall reimburse the Bank within fifteen (15) days after submission of the expense report.

-3-

8. THE COMPANY'S AUTHORITY.

Executive agrees to observe and comply with the reasonable rules and regulations of the Company as adopted by the Company's Board, either orally or in writing, respecting performances of his duties and to carry out and perform orders, directions, and policies stated by the Board, to him from time to time, either orally or in writing.

9. LEGAL DEFENSE; INDEMNIFICATION.

The Company acknowledges that the biotech industry is a highly litigious industry whereby many regulatory fines, penalties and third-party suits are directed at the individuals involved in ownership and operations. The Company agrees to pay all legal fees, judgments, awards, bonds, fines, penalties and costs related to the defense and outcome whereby Executive was acting in his corporate capacity. The Company acknowledges that from time to time the Executive becomes contingently liable for obligations of the Company. The Company will make whole the Executive in case such contingent obligations become direct. Also, in the event that Executive terminates the engagement with the Company for any reason, the Company will use its best efforts to remove the Executive from such liabilities, whether contingent or direct.

10. NOTICES.

All notices, requests, demands and other communications provided for by this Agreement shall be in writing and (unless otherwise specifically provided herein) shall be deemed to have been given three (3) days after having been mailed in any general or branch United States Post office, enclosed in a registered or certified postpaid envelope, addressed to the parties stated below or to such changed address as such party may have fixed by notice:

 TO THE COMPANY:      ICHOR CORPORATION
                      17 Dame Street
                      Dublin 2, Ireland

COPY TO:              James D. Chiafullo, Esq.
                      Cohen & Grigsby, P.C.
                      11 Stanwix Street, 15th Floor
                      Pittsburgh, PA 15222

-4-

BANK                 MFC Merchant Bank S.A.
                     6, Cours de Rive
                     P.O. Box 3540
                     CH-1211 Geneva
                     SWITZERLAND

This Agreement supersedes any and all Agreements, whether oral or written, between the parties hereto, with respect to the services of Executive performed for the Company and contains all of the covenants and Agreements between the parties with respect to the rendering of such services in any manner whatsoever. Each party to this Agreement acknowledges that no representations, inducements, promises or agreements, orally or otherwise, have been made by any party, or anyone acting on behalf of any party, which are not embodied herein, and that no other agreement, statement or promise with respect to such services not contained in this Agreement shall be valid or binding. Any modification of this Agreement will be effective only if it is in writing and signed by the parties hereto.

11. PARTIAL INVALIDITY.

If any provision in this Agreement is held by a court of competent jurisdiction to be invalid, void, or unenforceable, the remaining provisions shall nevertheless continue in full force and effect without being impaired or invalidated in any way.

12. GOVERNING LAW.

This Agreement will be governed by and construed in accordance with the laws of the State of Delaware.

13. BINDING NATURE.

This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective representatives, heirs, successors and assigns.

14. WAIVER.

No waiver of any of the provisions of this Agreement shall be deemed, or shall constitute a waiver of any other provision, whether or not similar, nor shall any waiver constitute a continuing waiver. No waiver shall be binding unless executed in writing by the party making the waiver.

-5-

15. TRANSFER.

This Agreement is a personal contract, and the rights and interests of Executive hereunder may not be sold, transferred, assigned, pledged or mortgaged except as otherwise expressly permitted by the provisions of this Agreement.

ICHOR CORPORATION

By: /s/ Pierre-Francois Serres
   ---------------------------------------
   Member of Board of Directors

MFC MERCHANT BANK, S.A.

By: /s/ John M. Musacchio
   ---------------------------------------
    John M. Musacchio

-6-

EXHIBIT A

ICHOR/MYMETICS
CHIEF OPERATING OFFICER RESPONSIBILITIES

This position reports to the President. The purpose of this position is to assist the President by having responsibilities in the following areas delegated to the Chief Operating Officer.

ADMINISTRATION AND FINANCIAL

o Establish, coordinate and manage the professional services, e.g., legal and accounting, required to fulfill the public company responsibilities of the Company.
o Establish, coordinate and manage the operations team with respect to contractual obligations of the Company.
o Manage the obligations of the Company to the lender.
o Monitor, measure and administrate the financial resources of the Company to responsibly fulfill its obligations to service providers and funders.
o Coordinate and fulfill the Company's legal obligations.
o Fulfill all financial reporting obligations.
o Fulfill all reporting obligations of the Company.
o Participate in the development of the Business Plan of the Company and a reporting system for management to utilize for measuring performance against the Plan.
o Manage the risk exposure of the Company vis a vis securities regulatory compliance and potential adverse legal actions from the investment, shareholder and biotech competitor community at large.
o Participate in the development of a Strategic Partnering strategy for the Company.

INVESTOR AND PUBLIC RELATIONS

o Identify key characteristics of the Board as perceived by the investment community and assist in identifying potential candidates.
o Coordinate the efforts of the Company's IR/PR team of Sarah Spaight and Burns McClellan.
o Manage and monitor implementation of the Company's business and communications strategy as defined by the CEO and the Board.
o Manage shareholder relations.
o Establish a viable US identity.
o Develop and implement a plan for positioning the Company for a listing on the NASDAQ Smallcap Market and subsequent equity raise.

-7-

Exhibit 10.(iii)

INDEMNITY AGREEMENT

THIS AGREEMENT dated for reference the 28th day of March, 2001.

BETWEEN:

MFC BANCORP LTD., a corporation incorporated under the laws of the Province of British Columbia, Canada and having an office at 17 Dame Street, Dublin 2 Ireland

("MFC")

AND:

ICHOR CORPORATION, a corporation incorporated under the laws of the State of Delaware in the United States and having an office at 17 Dame Street, Dublin 2 Ireland

("ICHOR")

WHEREAS:

A. ICHOR and certain shareholders of Hippocampe S.A. (the "Hippocampe Shareholders") entered into share exchange agreements (the "Share Exchange Agreements") dated for reference December 13, 2000 pursuant to which the Hippocampe Shareholders agreed to contribute their common shares of Hippocampe to ICHOR in exchange for the issuance by ICHOR to the Hippocampe Shareholders of shares of common stock or securities exchangeable into shares of common stock of ICHOR (the "Share Exchange"); and

B. It is a condition to the obligations of the Hippocampe Shareholders pursuant to the Share Exchange Agreements that ICHOR receive an indemnity from MFC, from and against all lawsuits, actions or similar claims arising out of the business and undertakings of ICHOR prior to the closing of the Share Exchange; and

C. MFC has agreed to indemnify and hold harmless ICHOR from and against all such lawsuits, claims or actions arising out the business and undertakings of ICHOR prior to the closing of the Share Exchange;

NOW THEREFORE THIS AGREEMENT WITNESSES THAT for and in consideration of the sum of $1.00 now paid by ICHOR to MFC, the promises, covenants and agreements hereinafter


set forth and provided for, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

PART 1
INTERPRETATION

1.1 DEFINITIONS

In this Agreement except as expressly provided or as the context otherwise requires:

(a) "AGREEMENT" means this Indemnity Agreement, and includes all amendments, supplements and restatements of this Agreement; and

(b) "EFFECTIVE DATE" means March 28, 2001.

PART 2
MFC'S COVENANTS AND INDEMNITY

2.1 MFC covenants and agrees to indemnify and save harmless ICHOR from and against any and all lawsuits, actions or similar claims which have been or may be asserted against ICHOR arising out of the business and undertakings of ICHOR prior to the Effective Date, net of any tax benefits to ICHOR, provided that nothing herein shall oblige MFC to indemnify ICHOR against payment of its obligations, in the ordinary course, as they come due.

PART 3
GENERAL PROVISIONS

3.1 This Agreement will enure to the benefit of and be binding on the parties and their respective successors and assigns.

3.2 This Agreement is to be governed by and interpreted in accordance with the laws of the Province of British Columbia.

3.3 Each party will execute and deliver such further Agreements, documents and assurances and do such further acts and things as either party reasonably requests to evidence and carry out and to give full force and effect to the intent of this Agreement.

3.4 This Agreement comprises the entire Agreement between the parties with respect to the subject matter hereof.


3.5 This Agreement may be executed by facsimile and in separate counterparts, each of which is an original, and all of which shall constitute one and the same instrument.

IN WITNESS WHEREOF the parties hereto have executed this Agreement as of the date and year first above written.

MFC BANCORP LTD.

By: /s/ J.M. Smith
   -----------------------------------------

Name: J.M. Smith
     ---------------------------------------

Title: President
      --------------------------------------

ICHOR CORPORATION

By: /s/ Pierre-Francois Serres
   -----------------------------------------

Name: Pierre-Francois Serres
     ---------------------------------------

Title: President
      --------------------------------------


Exhibit 10.(iv)

ICHOR CORPORATION

2001 STOCK OPTION PLAN

1. DEFINITIONS.

The terms defined in this Section 1 shall, for all purposes of this Plan, have the meanings herein specified:

(a) "ADMINISTRATOR" shall mean such one or more persons who shall have been appointed in accordance with Section 3.

(b) "BOARD" shall mean the board of directors of the Company.

(c) "CODE" shall mean the Internal Revenue Code of 1986, as amended.

(d) "COMMON STOCK" shall mean the Company's presently authorized Common Stock, except as this definition may be modified as provided in Section 8 hereof.

(e) "COMPANY" shall mean Ichor Corporation, a Delaware corporation.

(f) "DISABLED OPTIONEE" shall mean an Optionee who becomes disabled within the meaning of Section 422(c)(6) of the Code.

(g) "EFFECTIVE DATE" shall mean June 15, 2001.

(h) "EXCHANGE ACT" shall mean the Securities Exchange Act of 1934, as amended.

(i) "FAIR MARKET VALUE" shall have the meaning given that term in
Section 7(H) hereof.

(j) "NON-STATUTORY STOCK OPTION" shall mean an Option which does not qualify as an incentive stock option, as such term is defined in Section 422 of the Code.

(k) "OPTION" shall mean a Stock Option granted by the Company pursuant to the Plan to purchase shares of Common Stock.


(l) "OPTIONEE" shall mean a person who accepts an Option granted under the Plan.

(m) "OPTION PRICE" shall mean the price to be paid for the shares of Common Stock being purchased pursuant to a Stock Option Agreement.

(n) "OPTION PERIOD" shall mean the period from the date of grant of an Option to the date after which such Option may no longer be exercised. Nothing in this Plan shall be construed to extend the termination date of the Option Period beyond the date set forth in the Stock Option Agreement.

(o) "PLAN" shall mean this Ichor Corporation 2001 Stock Option Plan.

(p) "PARTICIPANT " shall mean key persons employed by the Company, or a Subsidiary thereof, directors of the Company, or a Subsidiary thereof, officers of the Company, or a Subsidiary thereof, and consultants to the Company, or a Subsidiary thereof.

(q) "STOCK OPTION AGREEMENT" shall mean the written agreement between the Company and Optionee confirming the Option and setting forth the terms and conditions upon which it may be exercised.

(r) "SUBSIDIARY" shall mean any corporation, partnership, business trust, joint venture or other business entity in which the Company owns, directly or indirectly through Subsidiaries, at least 50% of the beneficial interests or total combined voting power of all classes of equity.

2. PURPOSES.

The purposes of the Plan are to promote the growth and profitability of the Company and its Subsidiaries by enabling it to attract and retain the best available personnel for positions of substantial responsibility, to provide key Participants with an opportunity for investment in the Company's Common Stock and to give them an additional incentive to increase their efforts on behalf of the Company and its Subsidiaries.

3. ADMINISTRATION.

The Plan shall be administered by the Administrator. The Administrator shall be appointed by the Board and shall consist of at least three members of the Board, two of whom are non-employees of the Company. In the event that there does not exist at least two non-employee members of the Board, then the Administrator shall be comprised of the entire Board.

-2-

The Administrator shall have plenary authority in its discretion, subject to and not inconsistent with the express provisions of the Plan, (i) to grant Options, to determine the purchase price of the shares of Common Stock covered by each Option, the term of each Option, the persons to whom, and the time or times at which Options shall be granted, and the number of shares of Common Stock to be covered by each Option; (ii) to interpret the Plan; (iii) to prescribe, amend and rescind rules and regulations relating to the Plan; (iv) to determine the terms and provisions of the Stock Option Agreements (which need not be identical) entered into in connection with awards under the Plan; and (v) to make all other determinations (including factual determinations) deemed necessary or advisable for the administration of the Plan. The Administrator may delegate to one or more of its members or to one or more agents such administrative duties as it may deem advisable, and the Administrator or any person to whom it has delegated duties as aforesaid may employ one or more persons to render advice with respect to any responsibility or authority the Administrator or such person may have under the Plan. Notwithstanding the foregoing, each grant of an Option, and the terms thereof, to a member of the Administrator shall be approved by the Board.

The Administrator may employ attorneys, consultants, accountants or other persons, and the Administrator, the Company and its officers and directors shall be entitled to rely upon the advice, opinions or valuations of any such persons. All actions taken and all interpretations and determinations made by the Administrator in good faith shall be final and binding upon all persons who have received Options, the Company and all other interested persons. No member or agent of the Administrator shall be personally liable for any action, determination or interpretation taken or made in good faith with respect to the Plan or awards made thereunder, and all members and agents of the Administrator shall be fully indemnified and protected by the Company in respect of any such action, determination or interpretation.

4. ELIGIBILITY.

Subject to the provisions of this Plan, the Administrator shall determine and designate from time to time those key Participants of the Company or its Subsidiaries to whom Options are to be granted and the number of shares of Common Stock covered by such grants (subject to the approval of the Board in the case of a grant to a member of the Administrator). In determining the eligibility of an Participant to receive an Option, as well as in determining the number of shares covered by such Option, the Administrator (or the Board, in the case of a member of the Administrator) shall consider the position and responsibilities of such Participant, the nature and value to the Company or a Subsidiary of his or her services and accomplishments, his or her present and potential contribution to the success of the Company or its Subsidiaries and such other factors as the Administrator (or the Board) may deem relevant.

-3-

5. SHARES AVAILABLE UNDER THE PLAN.

The aggregate number of shares of Common Stock which may be issued or delivered and as to which Options may be granted under the Plan is 5,000,000 shares. All such shares are subject to adjustment and substitution as set forth in Section 8.

If any Option granted under the Plan is canceled by mutual consent or terminates or expires for any reason without having been exercised in full, the shares of Common Stock subject to such Option shall again be available for purposes of the Plan. The shares of Common Stock which may be issued or delivered under the Plan may be either or both authorized but unissued shares or repurchased shares, as shall be determined from time to time by the Board.

6. GRANT OF OPTIONS.

The Administrator shall have full and complete authority, in its discretion subject to the provisions of the Plan, to grant Options containing such terms and conditions as the Administrator shall deem appropriate in respect of the Non-Statutory Stock Options.

7. TERMS AND CONDITIONS OF OPTIONS.

Options granted under the Plan shall be subject to the following terms and conditions:

(A) The Option Price at which each Option may be exercised shall be such price as the Administrator, in its discretion, shall determine.

(B) The Option Price shall be payable in full in any one or more of the following ways:

(i) in cash; and/or

(ii) in shares of the Common Stock (which are owned by the Optionee free and clear of all liens and other encumbrances and which are not subject to the restrictions set forth in Section 9) having a Fair Market Value on the date of exercise of the Option which is equal to the Option Price for the shares being purchased.

If the Option Price is paid in whole or in part in shares of Common Stock, any portion of the Option Price representing a fraction of a share shall be paid in cash. The date of exercise of an Option shall be determined under procedures established by the Administrator, and the Option Price shall be payable at such time or times as the Administrator, in its discretion, shall determine. No shares shall be issued or delivered upon exercise of an Option until full payment of the Option Price has been

-4-

made. When full payment of the Option Price has been made and subject to the restrictions set forth in Section 9, the Optionee shall be considered for all purposes to be the owner of the shares with respect to which payment has been made. Payment of the Option Price with shares shall not increase the number of shares of Common Stock which may be issued or delivered under the Plan as provided in Section 5.

(C) No Non-Statutory Stock Option shall be exercisable after the expiration of ten years and six months from the date of grant, unless such period is extended by the Company. Subject to this Section 7(C) and Sections 7(E), 7(F) and 7(G), Options may be exercised at such times, in such amounts and subject to such restrictions as shall be determined, in its discretion, by the Administrator.

(D) No Option shall be transferable by an Optionee other than by will, or if an Optionee dies intestate, by the laws of descent and distribution, and all Options shall be exercisable during the lifetime of an Optionee only by the Optionee.

(E) Unless otherwise determined by the Administrator and set forth in the Stock Option Agreement:

(i) If the relationship between the Optionee (whether or not a Disabled Optionee) and the Company is voluntarily terminated with the written consent of the Company or a Subsidiary, or if an Optionee retires under any retirement plan of the Company or a Subsidiary, any then-outstanding Non-Statutory Stock Options held by such Optionee shall be exercisable (to the extent exercisable on the date of termination of employment) by such Optionee at any time prior to the expiration date of such Option or within three months after the date of termination of employment, whichever is the shorter period;

(ii) Following the death of an Optionee during his or her relationship with the Company, any outstanding Option held by such Optionee at the time of death shall be exercisable in full (whether or not so exercisable on the date of the death of such Optionee) by the person or persons entitled to do so under the will of the Optionee, or, if the Optionee shall fail to make testamentary disposition of such Option or shall die intestate, by the legal representative of the estate of such Optionee, at any time prior to the expiration date of such Option or within nine months after the date of death, whichever is the shorter period. Following the death of an Optionee after the termination of the Optionee's relationship with the Company during a period when an Option is exercisable

-5-

as provided in clause (i) above, any outstanding Option held by the Optionee at the time of death shall be exercisable by such person or persons entitled to do so under the will of the Optionee or by such Optionee's legal representative to the extent that such Option was exercisable by the Optionee at the time of death at any time prior to the expiration date of such Option or within nine months after the date of death, whichever is the shorter period;

(iii) If the relationship between the Company and the Optionee is terminated by the Company or a Subsidiary without cause, any then-outstanding Non-Statutory Stock Option held by such Optionee shall be exercisable (to the extent exercisable on the date of termination of employment) by such Optionee at any time prior to the expiration date of such Option or within 30 days after the date of such termination, whichever is the shorter period; and

(iv) If the relationship between the Company and the Optionee terminates for any reason other than voluntary termination with the consent of the Company or a Subsidiary, retirement under any retirement plan of the Company or a Subsidiary, death or involuntary termination without cause, the rights of such Optionee under any then-outstanding Option shall terminate at the time of such termination of the relationship. In addition, if an Optionee engages in the operation or management of a business, whether as owner, partner, officer, director, employee or otherwise and whether during or after termination of employment, which is in competition with the Company or any of its Subsidiaries, the Administrator may in its discretion immediately terminate all Options held by the Optionee. For purposes of this subsection (F), the following events or circumstances shall constitute "CAUSE", to wit: perpetration of defalcations; willful, reckless or grossly negligent conduct entailing a substantial violation of any material laws or governmental regulations or orders applicable to the Company or a Subsidiary; or repeated and deliberate failure, after written notice, to comply with policies or directives of the Chief Executive Officer of the Company or a Subsidiary or of the Board.

Whether termination of the Optionee's relationship is a voluntary termination with the written consent of, or an involuntary termination for cause from, the Company or a Subsidiary, whether an Optionee is a Disabled Optionee and whether an Optionee has engaged in the operation or management of a business which is in competition with the Company or any of its Subsidiaries shall be determined in each case by the

-6-

Administrator, and any such determination by the Administrator shall be final and binding.

(F) All Options granted hereunder shall be effective solely upon the delivery of a Stock Option Agreement, or an amendment thereto, duly executed by the Chief Executive Officer of the Company on behalf of the Company and by the Participant to whom such Options.

(G) Fair market value of the Common Stock shall be determined as follows:

(i) so long as the Common Stock is listed for trading on the NASDAQ Small-Cap Market the NASDAQ National Market or such other reliable publication as the Administrator shall, in its discretion, choose to rely upon, the fair market value of the Common Stock shall be determined by taking the average of the "bid" and "ask" prices per share of the Common Stock as quoted in such reliable publication on the trading date for the two week period ending on the last business day immediately preceding the date as of which fair market value is to be determined; or

(ii) in the event the Common Stock is not listed for trading on the aforementioned NASDAQ Markets or in such other reliable publications as may be acceptable to the Administrator, fair market value shall be determined (as of a date not more than 12 months preceding the date as of which such determination is required to be made hereunder) by an independent appraiser selected by the Board in its sole discretion. The appraiser shall be instructed to assess the fair market value of a minority interest in the Common Stock, taking into consideration such factors as the appraiser deems relevant, which factors may include but are not limited to (i) the Company's past, current and expected profitability, (ii) the Company's past, present and expected revenues and net cash flow, (iii) the Company's book value, and (iv) the absence of an organized tracking market for the Common Stock.

The date of the determination of the Administrator to grant an Option shall deemed to be the date on which an Option is granted, provided that the Participant to whom the Option is granted is promptly notified of the grant and an Option Agreement is duly executed as of the date of the resolution.

(H) The obligation of the Company to issue or deliver shares of the Common Stock under the Plan shall be subject to (i) the effectiveness

-7-

of a registration statement under the Securities Act of 1933, as amended, with respect to such shares, if deemed necessary or appropriate by counsel for the Company, and (ii) all other applicable securities laws, regulations, rules and orders which may then be in effect.

Subject to the foregoing provisions of this Section 7 and the other provisions of the Plan, any Option granted under the Plan shall be subject to such other terms and conditions as the Administrator shall deem advisable.

8. ADJUSTMENT AND SUBSTITUTION OF SHARES.

If a dividend or other distribution shall be declared upon the Common Stock payable in shares of Common Stock, the number of shares of Common Stock then subject to any outstanding Option and the number of shares which may be issued or delivered under the Plan but are not then subject to an outstanding Option shall be adjusted by adding thereto the number of shares which would have been distributable thereon if such shares had been outstanding on the date fixed for determining the stockholders entitled to receive such stock dividend or distribution.

If the outstanding shares of Common Stock shall be changed into or exchangeable for a different number or kind of shares of stock or other securities of the Company or another corporation, whether through reorganization, reclassification, recapitalization, stock split-up, combination of shares, merger or consolidation, then there shall be substituted for each share of Common Stock subject to any then-outstanding Option and for each share of Common Stock which may be issued or delivered under the Plan but is not then subject to an outstanding Option, the number and kind of shares of stock or other securities into which each outstanding share of Common Stock shall be so changed or for which each such share shall be exchangeable.

In the case of any adjustment or substitution as provided for in this
Section 8, the aggregate Option Price for all shares subject to each then-outstanding Option prior to such adjustment or substitution shall be the aggregate Option Price for all shares of stock or other securities (including any fraction) to which such shares shall have been adjusted or which shall have been substituted for such shares. Any new Option Price per share shall be carried to at least three decimal places with the last decimal place rounded upwards to the nearest whole number.

No adjustment or substitution provided for in this Section 8 shall require the Company to issue or sell a fraction of a share or other security. Accordingly, all fractional shares or other securities which result from any such adjustment or substitution shall be eliminated and not carried forward to any subsequent adjustment or substitution.

-8-

9. RESTRICTIONS ON TRANSFER OF CERTAIN SHARES.

The Company is authorized to (i) retain the certificate(s) representing such shares or place such certificates in the custody of its transfer agent,
(ii) place a restrictive legend on such shares, and/or (iii) issue a stop transfer order to the transfer agent with respect to such shares in order to enforce the transfer restrictions of this Section and Section 7(I) hereof.

10. EFFECT OF THE PLAN ON THE RIGHTS OF PARTICIPANTS AND EMPLOYER.

Neither the adoption of the Plan nor any action of the Board or the Administrator pursuant to the Plan shall be deemed to give any Participant any right to be granted an Option under the Plan, and nothing in the Plan, in any Option granted under the Plan or in any Stock Option Agreement shall confer any right to any Participant to continue his or her relationship with or remain in the employ of the Company or any Subsidiary or interfere in any way with the rights of the Company or any Subsidiary to terminate the its relationship with or employment of any Participant at any time.

11. INTERPRETATION, AMENDMENT, AND TERMINATION.

Except as provided elsewhere in this Plan, in the event of any dispute or disagreement as to the interpretation of this Plan or of any rule, regulation or procedure, or as to any question, right or obligation arising from or related to the Plan, the decision of the Board shall be final and binding upon all persons. The Board may, in its discretion, amend or terminate this Plan at any time. Termination of the Plan shall not affect the rights of Optionees or their successors under any Options outstanding and not exercised in full on the date of termination.

12. WITHHOLDING TAXES.

The Company unilaterally or by arrangement with the Optionee shall make appropriate provision for satisfaction of any obligation to withhold taxes in the case of any grant, award, exercise or other transaction which gives rise to a withholding requirement. An Optionee or other person receiving shares issued upon exercise of a Non-Statutory Option shall be required to pay the Company or any Subsidiary in cash the amount of any taxes which the Company or Subsidiary is required to withhold and the Company shall not be obligated to provide the Optionee with the Company's Common Stock until such time as such cash is paid to the Company.

Notwithstanding the preceding sentence and subject to such rules as the Administrator may adopt, Optionees who are subject to Section 16(b) of the Exchange Act, and, if determined by the Administrator, other Optionees, may satisfy the obligation, in whole or in part, by election on or before the date that the amount of tax

-9-

required to be withheld is determined, to have the number of shares received upon exercise of the Non-Statutory Option reduced by the number of shares the fair market value of which is equal to the withholding tax obligations.

13. EFFECTIVE DATE AND DURATION OF PLAN.

The effective date and date of adoption of the Plan shall be the Effective Date. No Option may be granted under the Plan subsequent to the date which is ten (10) years following the Effective Date.

-10-